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ABSTRACT 
 
Antimicrobial resistance is a world-wide health crisis (Infectious Disease Society of America 
[IDSA], 2016; World Health Organization [WHO], 2017) expedited by the overuse/inappropriate 
use of antibiotics. In the outpatient setting it has been determined that approximately 60% of 
antibiotic therapies are prescribed (Centers for Disease Control and Prevention [CDC], 2016). 
Antibiotic stewardship is the coordinated effort to improve the use of antibiotic therapies, 
minimize misdiagnosis and delayed diagnosis and select appropriate antibiotic drug regimens 
(IDSA, 2016). The purpose of this evidence-based practice project was to evaluate the effects of 
an antibiotic stewardship program (presentation, survey collection, bimonthly e-mail reminders, 
patient education) for providers to determine prescribing practices for bronchitis. Pre-
intervention, and post intervention chart audit for data collection was conducted based on the 
diagnosis code for bronchitis J20.9. Extensive literature review clearly supports bronchitis as the 
primary diagnosis which typically does not require antibiotic therapies (Schmidt et al., 2018). 
Outcomes measured included number of antibiotic prescriptions written for bronchitis before the 
antibiotic stewardship intervention and following the intervention. Also, the difference in 
prescribing rates for physicians and advanced practice registered nurses, also, provider 
attitudes towards antibiotic stewardship, and delayed prescribing. Chi-square test of 
independence was calculated comparing prescribing rates which remained consistent post 
intervention, (X2 (1) = 0.622, p >.05) indicating no statistical significance. An independent-
samples t test was calculated comparing the mean scores of nurse practitioners and physicians. 
No significant statistical difference was found (t (2) = 0.283, p > .05). However, survey results 
yielded positive responses congruent with attendance at the intervention presentation. 
Influenced by the antibiotic stewardship program nurse practitioners prescribing of antibiotics 
decreased from 85% pre intervention to 82.5% post-intervention. Providers agreed the overuse 
of antibiotics has contributed to the problem of drug resistance and that antibiotic education for 
the public is important. The implementation of an antibiotic stewardship program presents an 
inexpensive intervention for the annual reintroduction of the detrimental effects of the 
mis/overuse use of antibiotics for providers and patients.   
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CHAPTER 1 
INTRODUCTION 
Background 
Antimicrobial resistance is a multifaceted public health crisis, increasing the risk to the 
effective treatment of an escalating range of infections caused by bacteria, parasites, viruses, 
and fungi (Infectious Disease Society of America [IDSA], 2016; Dobson et al., 2017).  
Antimicrobial resistance may lead to serious health crises that may have far-reaching and 
lasting effects on society. It has been documented that in the United States 2 million infections 
and 23,000 deaths will occur per year due to antibiotic resistance (Centers for Disease Control 
and Prevention [CDC], 2016; Fleming-Dutra et al., 2016; Klepser et al., 2017; Richards, 2018) at 
a cost of over $20 billion (IDSA, 2017).  
Antimicrobial resistance threatens the actual treatment and prevention of infectious 
diseases caused by certain microorganisms. When exposed to antimicrobial drugs the alteration 
of the microorganisms of bacteria, fungi, viruses, and parasites begins (World Health 
Organization [WHO], 2017). These altered microorganisms render the medications given to 
patients useless on the illnesses and infections manifesting. Antimicrobial resistant infections 
then will cause death, contagion, and the potential for enormous costs (WHO, 2017).  
“Superbugs” are microorganisms that have developed resistance to many/most antimicrobials 
(WHO, 2017).   
Antimicrobial resistance is the term that covers the extensive spectrum of 
microorganisms and their resistance to antibiotics, antivirals, antifungals and antiparasitic 
medications (WHO, 2017). Antimicrobial resistance does occur over time, but it is expedited by 
the overuse/inappropriate use of antibiotics, such as a viral illness being treated with antibiotic 
therapy or the wrong medication for a bacterial infection being prescribed. There may also be a 
lack of infection control protocols and prevention measures in the clinic setting, as well as a 
decreased quality of prescription drugs available (WHO, 2017). Of greatest concern is that 
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common illnesses and infections that were once easily treatable are now resistant and this 
situation will increase morbidity and mortality within society (CDC, 2016). Without action, there 
will be a post-antibiotic era where once curable common infections and injuries will kill people 
yet again (WHO, 2017).   
Statement of the Problem 
 To fight antibiotic resistant bacteria, it is crucial to improve antibiotic prescribing 
practices in the outpatient clinic setting. Many antibiotic therapies, approximately 60% are 
prescribed in the outpatient setting with overuse of antibiotic therapy being common (CDC, 
2016; Drekonja, Filice, Greer, Olson, MacDonald, Rutks, Wilt, 2015). Within the adult population 
up to 50% of the antibiotic prescriptions may be inappropriate due to antibiotic selection, 
dosage, route, or duration of treatment, as well as unnecessary antibiotic treatment (IDSA, 
2016; CDC, 2016). Increased rates of prescribing also have the contributing factors of patient 
expectation, patient and provider unawareness of antibiotic resistance, and a lack of knowledge 
of the serious consequences of antimicrobial resistance. Obstacles to correct antibiotic 
prescribing may further be lack of clinical guideline and best practice knowledge, a high volume 
of patients with increased pressure for expedited visits, and unsatisfied patients if antibiotic 
prescriptions are not given (CDC, 2016; Drekonja et al., 2015)   
According to the CDC (2016) for the year 2013, 269 million antibiotic prescriptions were 
dispensed from outpatient pharmacies. For pediatric visits, 20% resulted in an antibiotic 
prescription, and 10% of adults received prescriptions in the outpatient setting. Consequences 
from antibiotic use may be self-limiting such as diarrhea or rash which are the most common, to 
respiratory airway edema that is classified as a severe adverse event, which is much less 
common. Severe adverse events account for approximately 140,000 emergency department 
visits per year (CDC, 2013). These visits are a contributing factor for excessive use of, at times, 
limited health care resources (CDC, 2016).   
ANTIBIOTIC STEWARDSHIP       
  3 
The most important risk factor for contracting a Clostridium difficile infection is antibiotic 
therapy (CDC, 2016; Drekonja et al., 2015; IDSA, 2016). Previously, C. Difficile infection (CDI) 
was considered a nosocomial pathogen, but it is increasing within the community (Klepser et al., 
2017). Zetts et al. (2018) references that if there is judicious use of antibiotic therapies this will 
have an impact on community acquired C. Difficile (CA-CDI) infections. Further, many studies 
have discovered that most patients with CA-CDI were treated with antibiotics in the weeks 
leading up to the infections (Richards, 2018; Zetts et al., 2018). If there is a 10% decrease in 
outpatient antibiotic prescriptions, it is estimated that there would be a 17% decrease in 
community associated C. difficile infections (CDC, 2016). 
Antibiotic stewardship in the outpatient setting will improve prescribing rates by 
clinicians, increase knowledge of use by patients for specifically only when needed, and help to 
ensure that when an antibiotic is prescribed it will be the right drug, dose, and duration of 
treatment. A program promoting antibiotic stewardship in the outpatient setting will improve 
patients’ outcomes, decrease adverse events, allow for patient and provider satisfaction, and 
may help to decrease the effects of antimicrobial resistance.   
Data from the Literature Supporting Need for the Project 
 The development of antimicrobial resistance has been several decades in the making. In 
1943, Penicillin was the first commercially available antibiotic. During the 1950’s through the 
1970’s, the introduction of 20 new classes of antibiotics deemed this period the “Golden Age of 
Antibiotics” (IDSA, 2016). Alexander Fleming, who discovered Penicillin, in his Nobel Prize 
speech from 1945 cautioned that “the public will demand these” and “bacteria could become 
resistant to these extraordinary drugs” (Ventola, 2015, p.278).    
For more than 60 years, antibacterial drugs have been regarded as the remedy to cure 
infections, whether their use is appropriate, and whether the infection was community or 
hospital acquired (IDSA, 2016). Within the microorganism, the development of resistance is a 
normal evolutionary process. But this process has been enhanced by the discerning pressure 
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applied by widespread use of antibacterial drugs (IDSA, 2016). Antibacterial drugs have been 
misused in humans and the animals we use for food, this misuse benefits the survival and 
spread of resistant bacteria (IDSA, 2016). This misuse has led to antibacterial drugs being less 
effective, or worse, ineffective which is a public health threat and an emergency presenting 
limited treatment options. The efficacy of existing antibiotic therapies should be maintained 
through processes that lessen the development and spread of resistance to these therapies 
(IDSA, 2016). Antibiotics save patients’ lives and have helped with numerous advances within 
modern medicine and surgery. Antibiotics have helped to extend expected lifespans by 
eradicating bacterial infections (Ventola, 2015). 
 Antibiotic stewardship is defined by multiple experts as “coordinated interventions 
designed to improve and measure the appropriate use of antibiotic agents by promoting the 
selection of the optimal antibiotic drug regimen including dosing, duration of therapy, and route 
of administration” (IDSA, 2016, p. 51). Defined by the CDC, antibiotic stewardship “is the effort 
to measure antibiotic prescribing; to improve antibiotic prescribing by clinicians and use by 
patients so that antibiotics are only prescribed and used when needed; to minimize 
misdiagnoses or delayed diagnoses leading to under use of antibiotics; and to ensure that the 
right drug, does, and duration are selected when and antibiotic is needed” (Sanchez, Dutra-
Fleming, Roberts, & Hicks, 2016, p. 1) 
 In 2015, the Joint Commission established antimicrobial stewardship criterion for 
hospitals, long term care centers and ambulatory care among others following a White House 
Forum on antibiotic stewardship (Joint Commission Perspectives, 2016). The White House 
Forum along with the Joint Commission gathered several stakeholders from professional and 
governmental organizations including the Centers for Medicare and Medicaid Services (CMS), 
the Society for Healthcare Epidemiology of America (SHEA) and the Centers for Disease 
Control and Prevention (CDC) (Joint Commission, Perspectives, 2016). These agencies agreed 
that there is an urgent need for an antimicrobial stewardship standard among all providers of 
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healthcare services in all settings. The main goals for antimicrobial stewardship are for strong 
leadership within the organizational setting to promote use of best scientific based guidelines 
and protocols, to promote staff and provider education along with monitoring regarding 
antimicrobial resistance and stewardship, and to promote a multidisciplinary team approach to 
assist with the organizational education of patients and families regarding antimicrobials. The 
Joint Commission endorses the core elements of leadership commitment, accountability, drug 
proficiency, action, tracking, reporting, and education (CDC, 2016; Joint Commission 
Perspectives, 2016).      
 Currently, there is no cost incentive to implement an antibiotic stewardship program in 
the outpatient clinic setting. Outpatient clinics and community pharmacies unlike hospitals and 
long-term care facilities have no opportunity to rationalize funding based on reductions in 
antibiotic expenses or decreased duration of stay (Klepser, Dobson, Pogue, Labreche, Adams, 
Gauthier, Brigg Turner, Su, Jacobs, Suda, 2017). Expert opinion is that funding for outpatient 
antibiotic stewardship should control incentives for provider participation (Klepser et al., 2017). 
An example of this would be preferred provider status within the clinic for antibiotic prescribing 
by meeting quality measures. Also, an explanation for funding aimed at compliance supporting 
documented scientific guidelines and standards may provide incentives for participation with the 
avoidance of fiscal consequences (Klepser et al., 2017).   
For the formation of an outpatient antibiotic stewardship program to be successful, the 
identification of the practice community and the stakeholders must be determined. For 
successful implementation of the program, goals and outcomes must be identified. Following 
team member acquisition, data analysis collection to define the focus of the antibiotic 
stewardship program will create the purpose of the program. The program outcomes must be 
concise and clear to avoid the creation of unmanageable expectations (Klepser et al., 2017). 
Outcomes to be measured within the antibiotic stewardship program may be, for example, 
clinical cures, treatment failures, antibiotic susceptibility patterns, guideline adherence, and 
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prescription data to highlight a few (Klepser et al., 2017). Since antibiotic resistant bacteria are 
not limited to the inpatient hospital setting with 66% of antibiotic use in the outpatient setting, 
there is an urgent need for antibiotic stewardship programs to be implemented the outpatient 
clinical setting.   
Data from the Clinical Agency Supporting Need for the Project 
 In the community ambulatory clinic setting the reduction of inappropriate use of antibiotic 
therapies will help with the reduction of infections due to antimicrobial resistant microorganisms. 
This reduction of prescribing practices will require the identification of barriers of prescriber 
behavior to promote change (Arnold & Straus, 2009). Organization leaders and stakeholders 
should commit to antibiotic stewardship. Clinic leaders need to be willing to help with the 
identification of obstacles that lead to divergence of best practice guidelines (CDC, 2016).   
In this evidence-based practice (EBP) project, one of the obstacles explored was the 
provider patient experience where pressure from patients for an antibiotic prescription is put 
upon the provider. This situation offered the opportunity to introduce the concept of a WASP 
(wait and see) prescription from providers. The basis of the WASP concept is that patients who 
are insistent, will be relieved to leave with the prescription, satisfied with the care received from 
the provider, and that the illness most likely will resolve and the prescription will not be filled 
(Arnold & Straus, 2009). Multifaceted interventions appear to be the most beneficial according 
to the literature sources. A step-by-step approach to interventions included evidence-based 
guidelines for providers, education for providers and patients, audit and feedback and WASP. 
Patients received educational brochures along with communication from their provider about 
antimicrobial therapies, risks, and benefits along with symptomatic treatment therapies to 
manage and alleviate symptoms (Arnold & Straus, 2009; CDC, 2016)   
A large community health care system with six locations and 45 providers was the 
optimal place to implement this EBP project. Currently, there is no formal program focused on 
antibiotic stewardship for providers and patients. The Director of Practice Improvement as well 
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as the Director of Quality Improvement anticipate a protocol for yearly review of antibiotic 
stewardship in the outpatient clinical setting from this initial implementation of the intervention. 
Purpose of the Evidence-Based Practice Project 
The purpose of this EBP project was to evaluate the intervention and implementation of 
an antibiotic stewardship program in the outpatient clinical setting for providers prescribing 
practices for bronchitis which typically does not require antibiotic therapies for treatment. Based 
on conversation with the Director of Practice Improvement, there currently is no formal antibiotic 
stewardship program in place. That said, according to the Director of Quality Improvement there 
does not appear to be a high number of providers inappropriately prescribing antibiotics for 
upper respiratory infections specifically bronchitis, but there has been no formal data analysis to 
determine so. But now these data will be determined following the pre-intervention chart audit.  
The project also impacts the patient experience with an increase in knowledge concerning 
antimicrobial resistance and antibiotic therapies. Antibiotic stewardship has the goal to 
maximize antibiotic treatment and minimize harm to the individual as well as communities (CDC, 
2016). 
Compelling Clinical Question 
The compelling question was: Will an outpatient antibiotic stewardship program increase 
provider awareness of inappropriate antibiotic prescribing for upper respiratory conditions 
specifically bronchitis, thereby decreasing the number of inappropriate prescriptions written 
while encouraging patient awareness of the detrimental effects of the use of antibiotic therapy 
when not required? The implementation of this multifaceted antibiotic stewardship program in 
the outpatient clinical setting will answer this question with data analysis and interpretation of 
results. 
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PICOT Question 
In the outpatient setting will an antibiotic stewardship program directed by national 
clinical guidelines and best practice vs. no program decrease the number of unnecessary 
prescriptions for bronchitis in a three-month period? 
Significance of the EBP Project 
The significance of this EBP project is binary. Antibiotics are prescribed too often for 
upper respiratory infections due to 90%-98% of the conditions being of a viral source and viral 
conditions will not improve with antibiotic therapies (IDSA, 2016). The CDC, WHO, and National 
Physician Alliance acknowledge that in clinical practice being a good steward is the 
ability/opportunity to decrease the prescription use of antibiotics for bronchitis, which also 
happens to be one of the top five applications of antibiotic stewardship (Holmes, Struwe, 
Waltman, 2018).   
Antimicrobial resistance is directly attributed to the overuse and inappropriate 
prescribing of antimicrobial therapies (CDC, 2016). Although the development of antimicrobial 
resistance does occur naturally, the overuse of antibiotics in the outpatient setting has increased 
and accelerated the rate of antimicrobial resistant microorganisms (WHO, 2017). The 
unnecessary use of antibiotics in the outpatient setting promotes antibiotic resistance, which 
leads to increased healthcare costs; and has the potential to expose patients to adverse events 
(Weddle, Holmes, Goldman, Myers, Newland, 2016). To combat antibiotic resistant 
microorganisms, antimicrobial prescribing must be better (CDC, 2016).   
Organizations must commit to antibiotic stewardship for the optimization of antimicrobial 
prescribing along with patient safety. As well as the commitment, there must be actions which 
may include a policy or procedure to improve the prescribing of antimicrobials, tracking and 
reporting of provider prescribing habits, and education for providers and patients about antibiotic 
stewardship (CDC, 2016). The antibiotic stewardship program will identify barriers, establish 
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standards, and identify high-priority conditions that require intervention such as antibiotic 
therapy for sinusitis (CDC, 2016). 
 Patients and families were provided education to evaluate perceptions of antibiotic use 
and to increase health literacy (CDC, 2016). Patients were informed that for viral infections 
antibiotics will not work, and that some bacterial infections may/will resolve on their own. 
Symptom management recommendations along with antibiotic therapy information is associated 
with an increase in patient satisfaction (CDC, 2016). Patient education included when to follow 
up or when to return if symptoms do not improve or if they get worse (CDC, 2016). Along with 
the enormous benefit that antibiotics have provided over the years there also is a possible harm 
associated with antibiotic use. Patients were made aware of possible side effects such as 
diarrhea, nausea, vomiting along with risk of adverse event such as airway restriction and C. 
difficile infections (CDC, 2016). Educational materials provided to patients about antibiotic use 
and when this use is needed and appropriate are a valuable tool and an offered an opening for 
providers to start the conversation of the risks, benefits, and possible harms associated with 
antibiotic use (CDC, 2016).     
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CHAPTER 2 
THEORETICAL FRAMEWORK, EBP MODEL, AND REVIEW OF LITERATURE 
This chapter provides a synopsis of the theoretical framework and EBP model guiding 
this project to include its applicability, strengths, and weaknesses. An overview of the synthesis 
and appraisal of the literature, the best practice recommendation, and how the best practice can 
answer the clinical question will be addressed. 
Theoretical Framework 
Overview of Theoretical Framework 
For successful implementation, of this EBP project, the theoretical framework chosen 
was Lewin’s Theory of Planned Change. According to the Lewin theory, when observing a 
situation, we must understand that there will be a “series of forces working in different 
directions” (Lewin, 1947, p. 341). Within the organizational setting, there will be forces eager to 
change and forces determined to maintain the current situation. Lewin’s method hypothesizes 
that behavior is a role of the group environment or field (Lewin, 1947; Borkowski, 2016) 
 To implement the proposed change (goal), the forces eager and willing to change must 
be increased; these are the driving forces (Lewin, 1947; Borkowski, 2016). The restraining 
forces, those who wish to maintain status quo must be decreased or cleared away. With the 
acknowledgment and understanding of each force, it was then possible to differentiate between 
the two, and to determine issues that may be changed and those issues that will remain 
unchangeable. A goal is that the new behavior will be continuous, current, and normal behavior.   
 The stages of Lewin’s Change model are unfreezing, change, and refreeze. Briefly, 
unfreezing involves getting ready for the change (Lewin, 1947). This stage involves the 
identification of the need to change, a change agent, and the identification of change 
champions, those willing to be involved with the change process. Within the unfreezing stage 
the identification of factors for and against change was determined. For the change to be 
successful the strengthening of forces for change and lessening of forces against change was 
ANTIBIOTIC STEWARDSHIP       
  11 
required. The change stage involved the intervention plan being implemented in the clinical 
setting. Also, the involvement of the change agents for coaching and reassurance that the 
change is relevant and valuable (Borkowski, 2016; Lewin, 1947; Shirey, 2013). The change 
agent is a cheerleader or champion. The requirement of the change agent is to promote the 
change. The change agent was available when questions or concerns arose and would help to 
propel the change forward. The final stage is refreezing. This stage encompasses the 
monitoring and evaluation of the new change for successful continuation and sustainability. This 
is the stage of the new normal. The change has been embedded in the facility and may remain 
permanent. 
Application of Theoretical Framework to EBP Project 
For the application of this framework, to the evidence-based practice project, the first 
step was to determine whether an antibiotic stewardship program was in place. Following 
consultation with the Director of Practice Improvement of the health care system it was 
determined that there was no requirement for providers and staff for a yearly program regarding 
antibiotic stewardship. Antibiotic stewardship programs are currently required for hospital and 
long-term care facilities that receive funds from the Centers for Medicare and Medicaid (CMS) 
Department of Health and Human Services (Joint Commission Perspectives, 2016). The 
outpatient clinic administration team has not been made aware of this requirement, but from our 
discussions, it was decided that an antibiotic stewardship program may, soon, be a requirement 
for federally funded clinics.   
After an extensive review of the literature the Core Elements of Antibiotic Stewardship 
from the Health and Human Services Centers for Disease Control and Prevention was chosen 
to guide the elements of the antibiotic program to be implemented (UNFREEZING). For this 
program to be successful the identification of stakeholders and key members was necessary. 
Along with the Director of Practice Improvement, the Director of Quality Improvement was 
recruited as well and promoted the program as a change champion as I did, the project leader, 
ANTIBIOTIC STEWARDSHIP       
  12 
as well. A chart audit prior to the intervention was conducted to determine prescriber rates and 
appropriate therapies for upper respiratory illnesses specifically bronchitis.   
For the implementation of the antibiotic stewardship program and the promotion of best 
practice, the literature supports the use of provider commitment, along with education, and audit 
with feedback will promote a successful outcome. Also, referenced within the literature is the 
recommendation of the appropriate actions for outpatient clinics to take as well as the 
incorporation of buy-in from major stakeholders within the organization (CHANGE).  
Strategies utilized to encourage the permanent change are the incorporation of EBP 
guidelines for the treatment of upper respiratory conditions including bronchitis, pharyngitis, and 
sinusitis which are the diagnoses supported within the literature. Based on data collection from 
the health care system and to further support the intervention, the diagnosis to target for 
inappropriate prescribing of antibiotic therapies was specifically bronchitis. Promotion of the 
antibiotic stewardship program via e-mail, as well as, onsite was implemented as a “nudge” for 
providers to remain committed to correct prescribing habits (REFREEZE).   
After a comprehensive review of the literature, it was determined that for antibiotic 
prescribers, the most frequent diagnosis of which inappropriate antibiotics were prescribed, is 
the category of upper respiratory infections, which include bronchitis, pharyngitis, and sinusitis. 
Providers received a training session about antibiotic stewardship, with feedback, as well as 
printed evidence-based guidelines for best practice for upper airway infections including upper 
respiratory infections and sinusitis. Providers also received tips and techniques for managing 
patients and parents of patients that demand an antibiotic for which there is no need (Rosenfeld 
et al., 2015, Wong et al., 2012; Zoorob et al., 2012).   
Strengths and Limitations of Theoretical Framework for EBP Project 
The strengths of the Lewin Change model are that it is easy to use, simple to 
understand, realistic and adaptable. Lewin’s Change model has been in existence for many, 
many years and thus there is a plethora of literature testifying to the usefulness, ease of use, 
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and relevance of the stages of the model. This model is most effective when used in a top-down 
approach for the implementation of a change (Shirey, 2013). For this project, formal leaders 
were very supportive and helped to promote the change. According to the research, change is 
successful when champions are in place to be the driving forces to propel the change forward 
(Borkowski, 2016; Lewin, 1947; Shirey, 2013). Further, according to the theory, change will be 
successful if there is buy in from stakeholders. The directors were willing and excited to be 
change agents for the promotion of the intervention. 
Limitations of the model also affect the EBP project. The model appears to be too 
simplistic. This model uses a three-step approach to change which was not realistic nor 
generalizable. This three-step approach to change followed a linear path with no exception for 
circumstance. Change is multifaceted and unpredictable; therefore, in the clinical setting it was 
not be possible to frame the project in a three-step scenario.   
Evidence-based Practice Model 
Overview of EBP Model 
The EBP model chosen for use with this project was the ARCC Model.  ARCC stands for 
Advancing Research and Clinical Practice through Close Collaboration (Melnyk & Fineout-
Overholt, 2015). This model strictly focuses on the implementation of best evidence-based 
practice along with promotion of sustainability system wide. This model has five steps. Step one 
was the assessment of the organization, the culture, and readiness for clinic wide change 
implementation. Step two was the recognition of strengths and limitations of evidence-based 
practice within the organization.  Step three was the identification of evidence-based practice 
advisors and guides. Step four was the implementation of evidence into practice, and step five 
was the evaluation of determined outcomes that have resulted from the practice change 
(Melnyk & Fineout-Overholt, 2015; Schaffer, Sandau & Lee, 2012) 
 This model has been used within the community clinic setting as well as hospitals and 
has been established as a plan for the improvement of practice outcomes. The ARCC model 
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highlights the organizational culture and the circumstances that support evidence-based 
practice.  The authors also clearly note that this model stresses organizational procedures to 
strengthen evidence-based practice within direct patient care, but that the decision-making 
process at the point of care must include provider expertise along with patient preference 
(Melnyk & Fineout-Overholt, 2015).  
Application of EBP Model to EBP Project 
The emphasis of the ARCC model is on organizational usage. For this project and step 
one of the model, the identification of organizational culture was determined as well as the 
readiness for change implementation. The large health care system with six offices and a total 
of 45 providers appeared to be the optimal setting for implementation of an outpatient antibiotic 
stewardship program. There currently is no program. The strengths of the organization are the 
administrative characteristics of an inviting and approachable attitude, as well as, progressive 
thinking with patient best interest at the forefront. The health care system also presents with a 
willingness to serve as a clinical cite for project implementation, with the future benefit of a 
sustainable organizational change which will then benefit the providers, patients, and 
community. This health care system serves a large, diverse population. The organization utilizes 
electronic health records (EHR) which support ease of data collection. Members of the 
implementation team included the project leader, director of practice improvement, and director 
of quality improvement. For implementation of evidence into practice, providers and patients 
were given information on antibiotic stewardship and best practice guidelines for upper 
respiratory illnesses.   
Step two of the model, the identification of potential strengths and barriers of EBP, was 
determined. Strengths identified are administrative support with a knowledge of EBP.  Barriers 
identified are a lack of a formal program and no determined champions. Future barriers to EBP 
may be individual providers unwilling to change or possibly providers having the attitude that 
antibiotic stewardship is someone else’s problem. Step three of the model, the use of EBP 
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mentors were identified. The project leader, director of practice improvement as well as director 
of quality improvement were recruited to serve as mentors. Step four of the model, the 
implementation of evidence into practice based on clinical guidelines, was the promotion of the 
antibiotic stewardship program in the outpatient setting. Finally, step five is the evaluation of the 
predetermined, chosen outcomes.   
Strengths and Limitations of EBP Model for EBP Project 
The ARCC model also has the goal of promoting the EBP team. The aim is to provide 
healthcare systems with an organized conceptual framework to guide system wide 
implementation and sustain evidence-based practice. The use of the ARCC model for promotion 
of an antibiotic stewardship program will improve quality of care and patient outcomes. The 
ARCC model also can be used to achieve high reliability organizational status. These 
characteristics include the ability to deliver safe and high-quality care, decrease costs, and 
improve providers’ job satisfaction (Melnyk, Fineout-Overholt, Gallagher-Ford, & Stillwell, 2011).   
A strength of the ARCC model included clearly identified steps for the implementation of 
EBP into the practice setting and the identification of champions to facilitate the EBP change.  
Also, the ARCC model is a tested method for improving practice outcomes with a reputation of 
proven experience in the community practice setting. The focus of the ARCC model is the 
promotion of sustainability system wide for EBP implementation.   
A barrier of the model may be provider knowledge deficit and use of EBP. Providers may 
see no value in EBP, this may lead to an unwillingness to acknowledge EBP and incorporate it 
into their practice. Another possible barrier may be a decrease in the buy-in from stakeholders 
to sustain and continue the project. Following implementation, the program may be allowed to 
fade away if champions and stakeholders see no real benefit. 
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Literature Search 
Research for relevant evidence was identified by searching multiple databases within the 
Christopher Center library system at Valparaiso University (see Appendix A). The search for 
evidence included the Cochrane Database of Systematic Reviews, The Cumulative Index to 
Nursing and Allied Health Literature, (CINAHL), Joanna Briggs Institute, MEDLINE, ProQuest, 
and PubMed, as well as National Guidelines Clearinghouse, Agency for Healthcare Research 
and Quality (AHRQ), and United States Health and Human Services Department Centers for 
Disease Control and Prevention. Key terms for the search included antibiotic, antimicrobial, 
stewardship, sinusitis, upper respiratory, systematic review, guidelines, prescribe, prescriber, 
therapeutic, use, pattern, outpatient, and ambulatory.  Boolean operators and mesh terms were 
applied to the search as well. Limiters for the search were English language, scholarly and peer 
reviewed, and the years between 2014 and 2018.  Additional studies were obtained by citation 
chasing from literature appearing with the qualifying criteria.   
Relevant literature abstracts were read for qualifying criteria for possible inclusion. 
Inclusion criteria included the years 2014-present and English language as well as evidence of 
documented guidelines from professional organizations supported by experts in the field. 
 Sources Examined for Relevant Evidence 
The results from the CINAHL search were 17. All abstracts were read for content and 
qualifying criteria with three being chosen to include in the literature review. The results for 
MEDLINE were 40. After reading all abstracts one was selected based on qualifying criteria. For 
the Cochrane Database, nine sources were identified, with abstracts read for content. One 
Cochrane review was chosen following abstract evaluation, then ultimately dismissed due to 
current research presenting with increased comprehensive content. Joanna Briggs Institute 
resulted in a very large number of sources, 110. Abstracts of most closely related criteria were 
read; none were chosen for review. The National Guideline Clearinghouse presented evidence-
based practice guidelines that were further searched to include one, the original guideline by the 
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American Academy of Otolaryngology through MEDLINE. The PubMed search resulted in 31 
sources of those, all abstracts were read for content with one selected for review. ProQuest 
presented the largest quantity of sources, 147, with all abstracts read for content with most 
closely qualifying criteria resulting in one chosen for review. The search of AHRQ and CDC 
resulted in several sources with relevant content aimed at antibiotic stewardship programs in the 
outpatient setting. Skimmed for content, the interventions most closely aligned with qualifying 
criteria for providers and patients resulted with one being selected for review.   
Levels of Evidence 
From this extensive literature search, many sources were identified for content that met 
inclusion criteria. Eight sources were chosen for the review and appraisal. All sources of 
evidence were ranked according to the Melnyk and Fineout-Overholt hierarchy of evidence 
(Melnyk & Fineout-Overholt, 2015). This appraisal methods ranks evidence in a top down 
approach with those sources at the top of the pyramid, the highest level of evidence, being a 
level one. Level one evidence includes clinical practice guidelines, and systematic reviews. 
Level one evidence has been shown to have a lower risk of bias and is generalizable to the 
population Level two evidence includes randomized control trials (RCT’s). These trials randomly 
assign participants to control or experimental group, and variables are the same for each group. 
Level three evidence includes controlled cohort studies. These studies follow participants over a 
period and the outcomes are measured and reported. Level four evidence includes uncontrolled 
cohort studies. These studies are of an observational method and no control was used to 
determine or maintain the participants or treatments. Level five evidence includes case studies 
and case series, qualitative and descriptive studies, EBP implementation and quality 
improvement projects. Level six evidence includes expert opinion. Once leveled, all sources of 
evidence were evaluated according to the Melnyk and Fineout-Overholt Rapid Critical Appraisal 
of Evidence, specifically, the Rapid Critical Appraisal of Guidelines and the Rapid Critical 
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Appraisal of Systematic Reviews and Randomized Control Trials (Melnyk & Fineout-Overholt, 
2015). 
A total of eight sources were selected. For the determination of best evidence-based 
practice, four clinical guidelines were ultimately chosen for inclusion. Clinical guidelines are a 
level one for strength of evidence according to Melnyk and Fineout-Overholt (2015) with high 
quality due to experts in the field being the researchers and creators of the guidelines. Also 
included are two systematic reviews that also are a level one for strength of evidence on the 
hierarchy by Melnyk and Fineout-Overholt (2015) with the quality being good due to the 
exhaustive search and inclusion criteria. Included as well are one randomized clinical trial and 
one retrospective cohort study. These studies are a level two and level four based on evidence 
respectively and were included based on the interventions presented within the literature, for 
example, provider commitment, that were ultimately implemented during the EBP project at the 
clinical site.    
Guidelines according to the hierarchy by Melnyk and Fineout-Overholt (2015) are a level 
one. The level one status is achieved when experts in the field develop the guidelines, direct the 
guidelines to additional experts, then interpret and challenge the results of the feedback to 
determine best practice. Review and feedback are the basis for the guideline that presents best 
evidence-based practice. Systematic Reviews conduct exhaustive research to determine 
eligible studies to be included within the data set. These reviews include tables with relevant 
information such as outcomes, interventions, prescribing rates/use, and summary. Also, an 
overview of strength of evidence is contained within several articles and deemed appropriate 
with confirmation of good, satisfactory, or poor. Following the appraisal and leveling of the 
evidence eight sources are included for review. Six level one, one level two and one level four. 
The overall quality of evidence based on the leveling system is good. 
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Appraisal of Relevant Evidence 
The appraisal of relevant evidence as shown in Appendix B was conducted according to 
the tools provided by Melnyk and Fineout-Overholt (2015). The Rapid Critical Appraisal of 
Systematic Reviews as well as Rapid Critical Appraisal of Guidelines were utilized. The 
appraisal of systematic reviews, as well as EBP guidelines, look to establish the credibility, 
transferability, applicability and generalizability that the chosen reviews and guidelines are 
presenting (Melnyk & Fineout-Overholt, 2015). Credibility has been determined due to the 
guideline developers being experts as well as major stakeholders in the field being represented 
(IDSA, 2016). The developmental strategy included an extensive, comprehensive review of 
literature that is easily reproducible (IDSA, 2016). Transferability is determined by the experts 
presenting explanations for diagnosis and treatment of common upper respiratory illness that 
may be utilized by family practice as well as other specialties (IDSA, 216). Within the guideline, 
recommendations for treatment are ranked with strength of evidence for use in practice as a 
strong recommendation, recommendation, or option (IDSA, 2016). Applicability and 
generalizability have been determined by the publication of the clinical guideline in the national 
practice journal as well as the presentation of standardization of clinical diagnosis and treatment 
(IDSA, 2016). These recommendations are clinically relevant and help in the care of patients 
(Melnyk & Fineout-Overholt, 2015). Further, these recommendations are practical, easy to 
implement, and are a reintroduction of best practice.  With the administration of EBP standard of 
care these outcomes will be analyzed and measured for this EBP project.  
Level I 
 The guideline provided by the CDC for review is based loosely on the previous versions 
of the guideline meant specifically for hospitals and long-term care facilities (CDC, 2016). This 
guideline is high quality due to adaptation and building on of best practice for antibiotic 
stewardship by systematic review which was researched and published in 2015 and 2016 
respectively. Further identified were subject matter experts in outpatient antibiotic stewardship, 
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best practice, implementation, and policy. Experts on subject matter provided feedback and 
suggestions for improvement prior to the final draft. This guideline outlines core elements for 
outpatient clinics to implement for best evidence-based practice (CDC, 2016). 
 The Infectious Disease Society of America (IDSA) presents a guideline for 
implementation of an antibiotic stewardship program that has involved a rigorous process which 
applied the GRADE system for evaluation of the strength of recommendation and quality of 
evidence (IDSA, 2016). The GRADE system briefly involves the confidence level of the 
evidence as well as the determination of strength involving balance of benefits and harms, 
patient preferences, resources, and cost, as well as an implication for the population, the policy 
maker, and the healthcare worker. To be labeled as a strong recommendation, most people 
would want the recommendation, most people should receive it, and the recommendation is 
adaptable as a policy (IDSA, 2016). 
 For intervention and implementation of the best practice antibiotic stewardship program, 
one of the required steps is EBP for upper respiratory conditions, including sinusitis. This clinical 
practice guideline is presented by The American Academy of Otolaryngology which is an 
updated (2015) clinical practice guideline for diagnosis and treatment of adult sinusitis. This 
guideline is intended for use by providers who are likely to see adults in the clinical setting. 
Included within the guideline is a summary of EBP statements with strength of evidence for use. 
Also included for clinic use by providers is a defined algorithm for adults with possible sinusitis. 
This guideline will help providers in caring for their patients as well as present a standard of care 
to measure outcomes related to the diagnosis and treatment of sinusitis (Rosenfeld et al., 
2015).   
 An additional guideline from Zoorob et al. (2012) and the American Academy of Family 
Physicians includes the diagnosis and treatment of upper respiratory conditions including 
bronchitis, pharyngitis, rhinosinusitis, as well as the common cold and influenza. Within this 
guideline, providers found key recommendations for practice with the stated evidence rating and 
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references. Also provided within the reading is a table with diagnostic findings along with 
appropriate treatment for common upper respiratory conditions.   
 Presented guidelines from the CDC (2015) and IDSA (2016) helped to serve as a guide 
within the interventions for implementation of an antibiotic stewardship program in the outpatient 
clinical setting. Guidelines recognized from the American Academy of Otolaryngology and the 
American Academy of Family Practice were presented to providers as a component of the 
multifaceted antibiotic stewardship program (CDC, 2015).   
 A systematic review by Drekonja et al. (2015) provides an evidence table on antibiotic 
stewardship interventions in the outpatient clinical setting. This review supplements and 
reinforces the CDC guideline for interventions which will be successful in decreasing the 
number of inappropriate prescriptions for upper respiratory conditions. For example, provider 
and patient education, communication skills training, and feedback for providers is included 
(Drekonja et al., 2015).   
 Finally, the systematic review by Keller et al. (2018) details the multiple interventions 
available for the provider in the clinical setting. Topics presented are provider education, audit 
and feedback, and communication techniques. Keller (2018) further presents information on 
interventions for the immediate clinic environment. These results are reproducible in the clinic 
setting with clinic outcomes that are relevant and important to best care. 
Level II 
 A randomized control trial (RTC) by Meeker et al. (2015) presented the benefits of a 
“nudge” in the form of a public display for the judicious use of antibiotic therapy in the outpatient 
clinical setting. This RTC demonstrated that the consistent use of a public display (poster and 
provider picture) was successful in changing prescribing behavior as well as influencing patient 
behavior for requesting antibiotic therapies. This intervention was low cost and easily 
implemented in the outpatient clinical setting. This intervention was also shown to decrease 
inappropriate antibiotic prescribing. 
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Level IV 
 A level four retrospective cohort study by Schmidt et al. (2018) demonstrated that 
provider and patient characteristics which may influence the inappropriate prescribing of 
antibiotic therapies for common upper respiratory conditions. Characteristics such as provider 
age and patient gender. Data extraction allowed for multiple factors to be analyzed. Specifically, 
provider prescribing rates as well as patient characteristics were presented in table form for 
ease of use. These interesting results further reinforced the need for an antibiotic stewardship 
program in the outpatient setting to be multifaceted with provider, patient and clinic interventions 
directed from within the organization.  
Construction of Evidence-based Practice 
Synthesis of Critically Appraised Literature 
Ultimately, from the literature review, it was determined that the first step for recognizing 
how to decrease inappropriate outpatient antibiotic prescribing is to assess diagnoses for which 
antibiotics are hardly ever, indicated (Schmidt et al., 2018). Further to ascertain provider 
commitment to antibiotic stewardship practices, incorporate best evidence-based practice 
guidelines from nationally recognized professional organizations, evaluate interventions based 
on provider, patient, and facility specifics, and then finally implement a program founded on 
evidence based best practice guidelines is needed (CDC, 2016; Drekonja et al., 2015; Dobson 
et al., 2017; IDSA, 2016; Schmidt et al., 2018).  
Provider Perceptions and Knowledge of Antimicrobial Stewardship/Resistance   
Within the literature it is noted that providers acknowledge the threat of antimicrobial 
resistance, disregard in some cases the seriousness of that threat (antimicrobial resistant 
microorganisms), and providers believe that antibiotic stewardship is a concern for every 
specialty setting (Drekonja et al., 2015; CDC, 2016; Arnold & Straus, 2009; Schmidt, Spencer, & 
Davidson, 2018; Zetts et al., 2018). All authors present the opinion that there is an agreement 
that the over use of antibiotic therapy is a chief reason for the emergence of antimicrobial 
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resistant microorganisms (Arnold & Straus, 2009; CDC, 2016; Drekonja et al., 2015; Schmidt, 
Spencer, & Davidson, 2018; IDSA, 2016; Rosenfeld et al., 2015; Zetts et al., 2018).   
Combating antimicrobial resistance with a defined and focused antimicrobial stewardship 
program is a priority most providers agree with (IDSA, 2016; Drekonja et al., 2015; Keller et al., 
2017; Meeker et al., 2015; Schmidt, Spencer, & Davidson, 2018; CDC, 2016; Arnold & Straus, 
2009). Zetts et al. (2018) and Fiore et al. (2017) described providers as being aware of 
inappropriate prescribing and overuse of anitbiotics, but deem the problem due to other 
providers practices mainly, not themselves.   
Provider Prescribing Practices and Patient Characteristics 
 Higher rates of antibiotic prescriptions from providers were associated with patient 
expectations and patient satisfaction, along with patient and provider knowledge deficits of 
antibiotic resistance (Drekonja et al., 2015; Keller et al., 2018; Meeker et al., 2015). Increased 
workload and decreased patient visit time are factors for an increase in providers prescribing 
practices (Zetts et al., 2018). Provider age was also determiners of prescribing rates (IDSA, 
2016). Provider age does appear to play a role in antibiotic prescribing practices (Meeker et al., 
2017). From the literature, it was noted that older providers were more likely to prescribe 
antibiotics inappropriately for upper respiratory conditions than their younger counterparts. 
Patient characteristics such as age and ethnicity, as well as insurance coverage effected the 
number of prescriptions written as well (Drekonja et al., 2015; Schmidt, Spencer, & Davidson, 
2018). As provider age increased, the likelihood of receiving an antibiotic prescription also 
increased up to the provider age of 61 years. For providers in the 51-60-year age group, the 
patient was four times more likely to receive the antibiotic as for prescribers younger than 30 
years of age (Schmidt et al., 2018).  
Patient characteristics of age, ethnicity, and insurance status also played a role in 
provider antibiotic prescription receipt (Meeker et al., 2017). For patient age 20-39 years, they 
were 4% less likely to receive an antibiotic than the patients who fell between 40-64 years of 
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age. For age, it was determined that older age increased the likelihood a prescription was 
provided possibly due to family responsibilities or return to work status (Schmidt et al., 2018). 
White patients were more likely to receive an antibiotic prescription than those of Asian or 
African American descent (Schmidt et al., 2018).   
 Commercial insurance patients were 10% more likely to receive an antibiotic prescription 
than patients with managed care plans. Patients with other forms of insurance such as no 
insurance, worker’s compensation, and self-pay were less likely to receive an antibiotic 
prescription (Schmidt el at., 2018). Patients with Medicare and Medicaid were less likely to 
receive an antibiotic compared to patients with commercial plans (Schmidt et al., 2018).   
Additional reasons for inappropriate prescribing were found in the literature and included 
defensive prescribing (departure from standard practice to prevent complaints), being unaware 
of current practice guidelines, patient demand, and clinic philosophy (IDSA, 2016; Meeker et al., 
2015).   
Providers consider patient demand a substantial factor when prescribing antibiotics and 
some providers believed patients expect actions (antibiotic prescription) that are substantial to 
address their illnesses (IDSA, 2016; Keller, Tamma, Cosgrove, Miller, Sateia, Szymczak, 
Gurses, Linder, 2018; Meeker et al., 2015; Zetts, Stoesz, Smith, & Hyun, 2018). Fiore et al. 
(2017) found mixed results with patient satisfaction when providers prescribe antibiotics in the 
outpatient setting.  According to Fiore et al. (2017), it appears that when providers explain why 
antibiotic therapy is not needed versus a provider who just writes the script, a higher level of 
satisfaction from patients is reported (Fiore et al., 2017). Zetts et al. (2018) and Meeker et al. 
(2017) also described a concern for the provider with experience of the threatened (possible) 
loss of patients, if the antibiotic prescription is denied. Further, Zetts et al. (2018) and Meeker et 
al. (2015) have revealed that providers may be seeing a decrease in this demand by patients 
due to increased media attention surrounding antimicrobial resistance.   
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Education & Feedback for Providers  
Provider education will be multifaceted and include current best practice guidelines, 
audit and feedback, and communication skills exercises. Clinical practice guidelines adhering to 
best practice published from national professional societies and organizations such as the 
Infectious Disease Society and the American Academy of Otolaryngology-Head and Neck 
Surgery should be utilized. This education will be in the form of a policy implementing the use of 
national guidelines for evidence-based treatment recommendations and diagnostic criteria 
(CDC, 2016 Drekonja et al., 2015; IDSA, 2016; Keller et al., 2018; Meeker et al., 2015; Schmidt 
et al., 2018; Zetts et al., 2018). Drekonja et al. (2015) references that within published studies 
concerned with antibiotic use, there was a significant decrease in prescribing following 
implementation of best practice guidelines. Keller et al. (2018) and IDSA (2016) described 
providers who attended evidence-based education for antibiotic stewardship focused on upper 
respiratory conditions showed a decrease in antibiotic prescribing over a 30-month period. And 
for providers attending education as well as feedback with peer review sessions, the reduction 
in prescribing inappropriately decreased from 54% to 27% which was sustainable for 2-3 years 
(Keller et al., 2018) 
Commitment from Providers 
Provider commitment to antibiotic stewardship as presented within the literature is the 
implementation of an intervention for antibiotic stewardship. A provider signed poster in the 
waiting area committed to appropriate antibiotic prescribing, as well as posters in exam rooms 
stating appropriate use of antibiotics will be verification of provider commitment (Meeker et al., 
2015; Zetts et al., 2018). Commitment letters signed by providers posted in examination rooms 
may lead to a decrease in inappropriate antibiotic prescriptions (Meeker et al., 2015; Zetts et al., 
2018). Along with the commitment letter, a picture of the provider as well as a signature from 
that provider on the letter stating a commitment to avoid inappropriate antibiotic prescribing led 
to a decrease in the number of inappropriate antibiotic prescriptions by providers and requested 
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by patients (Zetts et al. 2018). This intervention was prescriber specific in that providers had 
their own exam rooms and there was no movement of patients within the different provider 
exam rooms. This low-cost intervention of the posted letter committing to avoiding inappropriate 
antibiotic prescriptions if implemented across the United States “could eliminate 2.6 million 
unnecessary antibiotic prescriptions and save 70.4 million annually on drug costs alone” 
(Meeker et al., 2015, p. 8). According to Meeker et al. (2015), public commitments such as the 
signed poster in the waiting area indicate suggested intervention follow through is successful 
with decreasing inappropriate antibiotic prescriptions. 
Action to be Taken by Providers 
 Communications skills training for providers improved patient and provider experience 
which addressed patient concerns and questions regarding treatment options for illness and 
diseases (CDC, 2016). Strategies to inform patients of the harms and benefits of antibiotic 
therapy and the symptomatic management of illness will increase patient awareness (CDC, 
2016).  Providers also must have the tools needed to manage patient expectations and the 
disappointment certain patients will feel with not receiving an antibiotic during an outpatient visit 
(Keller et al., 2018; Meeker et al., 2015). Provider decision support through the EHR showing 
diagnosis and treatment in print form for patients to have and take with them at the end of the 
visit decreased inappropriate antibiotic prescriptions (CDC; Sanchez, Guillermo V; Dutra-
Fleming, Katherine E; Roberts, Rebecca M; Hicks, Lauri A, 2016; Keller et al., 2018). 
Tracking and Reporting 
Tracking and reporting of antibiotic prescribing practices, also referred to as audit and 
feedback, were used to encourage practice change and to assess antibiotic prescribing 
practices, and to determine whether an increase or decrease in prescribing is noted. The 
approach to track and report on identified conditions such as upper respiratory infections can be 
implemented to assess antibiotic therapy appropriateness, correct diagnosis and antibiotics 
given, and if dose and duration were correct according to best evidence-based practice (IDSA, 
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2016; Meeker et al., 2015;).  Keller et al. (2018) IDSA, (2016) and Zetts et al. (2018) agreed that 
interventions which incorporate audit and feedback have been successful. While Zetts et al. 
(2018) and the CDC (2016) described the audit of providers who were made aware of their own 
personal prescribing practices “significantly improved prescribing habits for common acute 
respiratory tract infections” (p.6).  However, Keller et al. (2018) found that for providers with high 
prescribing rates and who received data about their habits “did not impact antibiotic prescribing 
over 2 years” (p.424). This negative effect was possibly due to providers receiving written 
communication about prescribing habits, which then required the provider to follow-up 
electronically. Related to a substantial decrease in inappropriate antibiotic prescribing was 
individualized feedback for providers regarding their individual antibiotic prescribing rates (CDC, 
2016; IDSA, 2016; Drekonja et al., 2015; Keller et al., 2018; Schmidt et al., 2018) 
Delayed Prescribing 
 Delayed prescribing, the WASP (wait and see prescription), and watchful waiting all 
have been described in the literature as useful techniques for promotion of antibiotic 
stewardship and best practice (CDC, 2016; Drekonja et al., 2015; Keller et al., 2018). For this 
prescribing technique, the patient is given a prescription with explicit instructions for when to 
have it filled. Drekonja et al. (2015) summarized that along with patient education or no 
education from provider, the delayed prescribing technique resulted in a significant reduction in 
prescription use. Further, the recommendation states for providers to inform patients to call if a 
condition does not improve or gets worse and at that time providers may give the prescription 
for antibiotic therapies if warranted. Best EBP promotes symptomatic treatment with watchful 
waiting and delayed prescribing for illnesses to safely decrease overuse antibiotic therapies 
(CDC, 2016).        
Best Practice Model Recommendation 
Inappropriate use of antibiotics contributes to the development of antibiotic resistant 
microorganisms. Antibiotic stewardship programs in the outpatient clinical setting are designed 
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to lessen this risk by confirming that these antibiotics are prescribed only when required and if 
prescribed, prescribed appropriately. Providers must adhere to EBP guidelines to ensure that 
patients receiving antibiotics for a bacterial infection are prescribed the correct drug, dose, and 
duration of treatment (CDC, 2016; IDSA, 2016; Rosenfeld, 2016; Wong, 2006; Zoorab, 2012).   
 Meeker et al. (2015) and Richards (2018) acknowledged that commitment from 
providers for appropriate antibiotic prescribing within the antibiotic stewardship program may 
include posters and commitment letters located within the clinic and individual patient rooms. 
Further, education for providers must be a multifaceted approach. This education must include 
distribution of guidelines, hard copy or electronically, committed to best practice. Audit and 
feedback as well as training to improve the patient provider communication experience is noted. 
Patient questions and concerns addressed in a courteous, professional, and informative manner 
from the provider will increase patient satisfaction and decrease the number of inappropriate 
antibiotic prescriptions given.   
 Tracking prescribing rates while utilizing audit and feedback allowed for identification of 
“top performers”, those providers who adhere to best practice guidelines and have low antibiotic 
prescribing rates. As noted within the literature, this intervention “significantly reduced 
inappropriate prescribing” (Zetts, Stoesz, Smith, & Hyun, 2018, p. 6). According to IDSA (2016), 
a fundamental element of any antibiotic stewardship program should include audit and feedback 
to determine prescribing rates. Once rates are determined, this information should be made 
available to the individual prescribers with status noted as well as ways to improve prescribing 
habits. Providers must further be given education regarding patient characteristics and 
preferences for antibiotic therapies. Education must extend to patients in the form of 
explanations mainly from providers with support of clinic staff concerning the inappropriate use 
of antibiotics and that this may lead to adverse events and possible serious infection with C. 
difficile (CDC, 2016; Drekonja et al., 2015; Fiore et al., 2017; IDSA, 2016; Zetts et al., 2018) 
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Model Elements 
 Antibiotic stewardship programs in the outpatient clinical setting (see Figure 1) will be 
beneficial to patients as well as providers to help to decrease the number of inappropriate 
antibiotic prescriptions requested by patients and written by providers.   
1.  Evidence Based Guidelines The utilization of best practice guidelines will help providers 
determine appropriate antibiotic therapy based on clinical presenting illness and present a plan 
for treatment which will include best drug, dose, and duration of therapy.   
2.  Commitment and Education Written education for providers combined with educational 
material was given to patients. Antibiotic stewardship, guidelines, symptomatic treatment, and 
EHR or CDC information will open the dialogue to increase patient and community knowledge of 
the detrimental effects of using antibiotic therapy when not required. Delayed prescribing of 
antibiotic therapies with symptomatic treatment has been shown to decrease inappropriate 
antibiotic use. Communication skills exercises for providers to increase their confidence level 
when patients demand antibiotic therapies which are not warranted were included. 
3.  Tracking and Reporting As previously stated, audit and feedback of individual prescribing 
rates offered providers the opportunity, without any requirement from the provider, to obtain “top 
performer” status. Top performers may be defined by predetermined outcomes such as quality 
measures checked, individual prescribing rates for conditions not routinely requiring antibiotic 
therapies, and patient feedback.   
4.  Experience and Expertise Provider expertise and experience included communication for 
patients concerning the detrimental effects of using antibiotic therapies when not warranted. 
Providers can use the techniques provided to manage patients who demand treatment with 
antibiotics. This dialogue will hopefully become routine, not a point of contention or challenge, to 
incorporate into practice. Visual prompts in the form of commitment letters and posters are 
reminders for providers and possible conversation starters for patients of the consequences of 
inappropriate antibiotic therapies. Providers are encouraged to speak with an expert that may 
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assist with improving prescribing rates, such as a pharmacist. Finally, clinic leaders were 
mentors for promotion of best evidence-based practice for antibiotic stewardship programs 
which will lead to overall decreased health care costs and most importantly better outcomes for 
patients their families, and communities. 
 
Figure 2.1  
 
Best Practice Model Presentation 
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How the Best Practice Model Will Answer the Clinical Question 
The best practice model answered the clinical question of: Within the outpatient clinical 
setting will an antibiotic stewardship program directed by national clinical guidelines and best 
practice decrease unnecessary prescriptions for upper respiratory illnesses specifically 
bronchitis, while increasing provider knowledge as well as increasing patient and community 
knowledge regarding the detrimental effects of using antibiotic therapy when not required?  
The implementation of an antibiotic stewardship program (see Figure 2.1) directed by 
national clinical guidelines and best practice in the outpatient clinic setting did not decrease 
unnecessary antibiotic prescribing by providers. Providers were made aware of their prescribing 
practices and were then encouraged to earn “top performer” status. Also, an increase in the 
knowledge base of patients, families, and communities of the detrimental effects of using 
antibiotic therapies when not warranted which may lead to adverse events as well as C. difficile 
infections is essential to best practice. Comprehensive multifaceted antibiotic stewardship 
programs recognize and support initiatives that are being taken and recommendations being 
made to minimize harm, diminish unnecessary and inappropriate antibiotic therapy, and reduce 
the unnecessary use of systemic antibiotics which is a major contributing factor in the 
development of antimicrobial resistant organisms (CDC, 2016; Rosenfield et al., 2015).   
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CHAPTER 3 
IMPLEMENTATION OF PRACTICE CHANGE 
  Successful implementation of an antibiotic stewardship program in the outpatient clinical 
setting is efficacious following extensive, exhaustive literature review with synthesis to 
determine best practice and best approach. Lewin’s Theory of Change model and the ARCC 
model were used as frameworks for implementation of the program. Antibiotic stewardship is 
the most important way to decrease inappropriate use of antibiotic therapies, thereby 
decreasing the number of antibiotic resistant organisms (CDC, 2016; WHO 2017). Within this 
process, the protection of providers and patients who participated in the implementation of this 
project was maintained.  
During the planning for this EBP project, the steps for Internal Review Board expedited 
review process were followed to ensure ethical treatment of all participants. Further, the project 
leader successfully completed The National Institutes of Health (NIH) Office of Extramural 
Research course “Protecting Human Research Participants”. The implementation phase 
involved assessing the environment where the intervention was needed, planning the antibiotic 
stewardship program, and the protection of the confidential materials collected. Institutional 
Review Board (IRB) proposal was approved (see Appendix D). Permission was granted to the 
project leader from the health care center to commence with the project during the pre-stated 
times (see Appendix E).  
Antibiotic stewardship in the outpatient setting is a multifaceted approach for providers, 
staff, and patients. Briefly, the implementation of this program was directed to providers with a 
planned approach at the monthly staff meeting which all providers were required to attend. This 
method presented a survey, PowerPoint® presentation, question and answer session, and 
finally distribution of hard copies of EBP for antibiotic therapy for the most commonly diagnosed 
upper airway conditions that normally do not require antibiotic therapy. Also, included within the 
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printed material was the article by Fiore (2015) which summarized techniques for providers 
when confronted by a patient demanding antibiotic therapy when not required.   
The patient portion of the outpatient antibiotic stewardship program included printed 
material in the form of a trifold from the Centers for Disease Control and Intervention (2018) “Be 
Antibiotics Aware” with the harms associated with using antibiotic therapy when not needed and 
the explanation of antibiotic resistance. This form is available in English and Spanish in the 
clinic. Posters in the clinic included: An Antibiotic is the Wrong Tool to Treat a Virus; Do you 
need antibiotics? and a chart, Viruses or Bacteria What’s Got You Sick? (CDC, 2018). These 
materials are written in basic language for reading at the 8th grade level. Posted areas included 
any/all reception areas where patients were waiting for individual scheduled appointments for 
the delivery of visual confirmation. 
Participants and Setting 
Participants for this EBP project, a multifaceted antibiotic stewardship program, were the 
providers, staff, administrators, ancillary staff, and patients of a large multi-site northwest 
Indiana health care agency.  The clinical site agency is a non-profit federally qualified 
community health care system with multiple clinic locations. The clinical site agency provides 
care to patients regardless of ability to pay.  These health care centers provide high quality, 
affordable health care to all patients, the uninsured, underinsured, and insured. Clinic sites 
accept Medicare and Medicaid, Hoosier Healthwise, as well as private insurance. Coordinators 
also will help with the navigation process of applying for Medicare and Medicaid for those 
patients that require assistance. Clinic sites also offer a sliding scale based on income for those 
with no medical insurance who qualify. Clinic providers offer the spectrum of healthcare from 
pregnancy, pediatrics, adult care, urgent care, chronic diseases as well address issues of 
homelessness and other obstacles related to the inability with no opportunity to prioritize health 
care. This multi-site organization receives Health and Human Services funding and has Federal 
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Public Health Services (PHS) status for certain health or health related claims in the outpatient 
clinic for covered patients.   
Outcomes 
Outcomes measured included the number of inappropriate antibiotic prescriptions written 
for common upper airway conditions that normally do not require antibiotic therapies. Included 
unanimously and consistently is the condition of bronchitis based directly on literature review. 
The ICD-10 code was utilized to determine qualifying patient visits for this diagnosis. Patient 
characteristics were age, gender, comorbidities, and medical record number (MRN) number. 
Prescribing provider information was also included. Also, a secondary outcome that was 
determined included if there was a difference in prescribing practices for physicians and 
advanced practice nurses. A retrospective random chart audit was conducted to retrieve 
patients for the months of November 2017-January 2018 that met the qualifying criteria 
compared to those during the intervention period of November 2018-January 2019. A third 
outcome that was measured was the applicability of the WASP or delayed prescribing technique 
in the outpatient clinic setting. 
Intervention 
A multifaceted-antibiotic stewardship intervention program involved the presentation 
introduced at the mandatory provider meeting. Providers were encouraged to complete a 10-
question survey concerning their opinions of antibiotic stewardship and their own prescribing 
practices as well as their opinion of overall practice promotion of antibiotic stewardship (see 
Appendix F). A PowerPoint® presentation based directly on the CDC’s Core Elements of 
Outpatient Antibiotic Stewardship was offered. Following the PowerPoint® presentation, the 
floor was open for questions of which there were none. To conclude, printed materials were 
provided in the form of best evidence for treatment of common upper respiratory conditions 
based on current clinical guidelines from the American Academy of Otolaryngology (CDC, 2016; 
IDSA, 2016). Providers were offered the opportunity sign posters to be displayed in the waiting 
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areas promoting antibiotic stewardship. These posters served as the visual commitment from 
providers for antibiotic stewardship. Lastly, providers received printed copies of techniques for 
individual provider use to deter the patient or family requesting antibiotic therapy when not 
warranted.   
Patient intervention included posters within waiting areas describing antibiotic therapies, 
viral and bacterial symptoms, and the detrimental effects of using antibiotic therapies when not 
required. A tri-fold pamphlet was available for patients to identify when it is appropriate to use 
antibiotics and the explanation of antibiotic resistance.   
Planning 
For the planning of this multifaceted antibiotic stewardship program in the outpatient 
setting, the utilization of the CDC’s Core Elements of Antibiotic Stewardship was applied (CDC, 
2016). The practice change timeframe was three months. Phase one included the introduction 
of the multifaceted antibiotic stewardship program to the providers at the monthly mandatory 
staff meeting held in September. Phase two included the promotion of the program with the 
displaying of the provider signed posters in waiting areas of all clinics. Clinical champions 
promoted the intervention. Also, there was distribution of educational materials for patients 
divided among the clinics for use and circulation by providers and staff. Phase three was the 
continued promotion of the antibiotic stewardship program through bimonthly email reminders to 
providers. Following the closure of the predetermined time frame, the project leader conducted 
a post intervention chart audit of the predetermined outcomes to determine the effectiveness of 
the program.  
Antibiotic resistant microorganisms are one of the greatest threats to humans now and 
into the future as evidenced by the approximately 2 million infections and 23,000 deaths per 
year (CDC, 2016). An increase in morbidity and mortality with the increase of antimicrobial 
resistant microorganisms is expected (CDC, 2016; WHO, 2017). Increased health care costs 
will be directly related to antimicrobial resistant infections (CDC, 2016). Antibiotic stewardship 
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programs can determine the degree of antibiotic prescribing and to improve antibiotic 
prescribing by providers and use by patients so that antibiotics are only prescribed and used 
when needed. Additionally, these practices will minimize misdiagnoses or delayed diagnoses 
leading to underutilization of antibiotics and make certain that the right drug, dose, and duration 
are selected when an antibiotic is warranted (CDC, 2016). The project plan was directed by the 
project leader with support from the Director of Practice Improvement and the Director of Quality 
Improvement. 
Data 
Measures 
Providers completed a 10-question survey (see Appendix F) to determine their beliefs 
and attitudes about antibiotic stewardship, along with information about their own personal 
prescribing practices in the clinical setting. The survey was developed by the project leader and 
included five knowledge-based questions and five questions concerned with prescribing 
practices. These questions were extracted from the literature to support their validity. A five-
point Likert Scale, ranging from one extremely likely, two likely, three neutral, four unlikely, and 
five extremely unlikely were used for the determination of prescribing practices. Providers were 
encouraged to complete the survey honestly and without fear of retribution or disclosure of 
content to others. Chart audit parameters included patient characteristics, provider type, and 
antibiotic therapy. All data collected were reviewed and verified for accuracy.  
Collection 
Survey collection from providers was conducted through an online survey service. These 
data were analyzed for presenting themes. Data collection was conducted through a 
retrospective chart audit with the parameters of diagnosis, patient characteristics, MRN, and 
provider for the dates of November 2017 through January 2018. Although the literature supports 
a slightly longer time period, most upper respiratory infections are in fact diagnosed in the 
Winter (CDC, 2015). The data set and time frame allowed the project leader to determine 
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outcomes in a timely manner. These data were analyzed to determine additional themes 
presenting along with determined outcomes of number of inappropriate prescriptions and 
provider type. Following antibiotic stewardship program implementation in September 2018, a 
chart audit was completed for the date range of November 2018-January 2019. Data was 
analyzed using the exact parameters as the retrospective chart audit with the expectation that 
the outcomes measured would be apparent, and relevant to the project. Patients receiving a 
WASP were contacted by the project leader to determine if the prescription was not filled, which 
was the aim of the WASP, delayed prescribing technique.   
Management and Analysis 
Data management was maintained through passwords protected accounts. Provider 
surveys were kept separately, and data securely destroyed following coding and inclusion for 
data analysis. This intervention was aimed at providers with no patient requirement nor 
involvement. Spread sheet analysis of the predetermined parameters was conducted by the 
project leader. Data collected from pre-intervention and post-intervention chart audits was 
anonymous for patient identifiers. Statistical analysis and testing were performed using the IBM 
SPSS statistics 25 software. Chi square was used to determine any differences between the 
two groups of nominal data for pre-intervention and post intervention data for physicians vs. 
nurse practitioners (Cronk, 2017). An independent t- test was used to determine the results of 
the outcomes of the intervention on pre-data and post data (Cronk, 2017). 
Outcomes 
The primary outcome and initial goal, following implementation of the program, was to 
report a decrease in the number of unnecessary prescriptions being given for upper respiratory 
illnesses specifically bronchitis which does not usually require antibiotic therapies.  The illness 
for inclusion is bronchitis, based on the literature review. To determine the initial prescribing 
characteristics, a retrospective chart audit was conducted using the parameters of age, gender, 
ethnicity, date of service, comorbidities, smoking status, diagnosis code, physician or nurse 
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practitioner (NP), antibiotic prescribed, and antibiotic name if prescribed. Encounter number was 
also included for use by the project leader if warranted or questions arose. Following 
implementation of the program, with bimonthly reminders, a chart audit was conducted using the 
same parameters to determine prescribing rates post intervention.  
The second outcome measured was if there was a difference in the prescribing rates 
between physicians and NP’s. Holmes et al. (2018) found that in the months following an 
antibiotic stewardship program, providers wrote fewer prescriptions for antibiotics, and providers 
were more likely to limit the number of antibiotic prescriptions given. According to Weddle et al. 
(2017), antibiotic stewardship programs can be successful for decreasing unnecessary antibiotic 
prescribing. Zetts et al. (2018) concludes that while primary care providers account for the 
largest number of outpatient antibiotic prescriptions, NP’s play an important part in the 
promotion of antibiotic stewardship and should be involved in the future efforts of the program. 
The third outcome measured was the effect of the WASP or delayed prescribing 
technique and efforts by the provider. Delayed prescribing, as noted within the literature, has 
shown to decrease the number of prescriptions being filled by patients (CDC, 2016; Drekonja et 
al., 2015; Keller et al., 2018).  Further, delayed prescribing has a positive effect on the patient 
experience, patients are satisfied with the care received if they obtain a prescription (Arnold & 
Straus, 2009). Patients receiving the WASP were contacted by the project leader to determine if 
the symptoms subsided and if the prescription was filled or not, which is the aim of this 
technique. 
 
 
 
 
 
 
ANTIBIOTIC STEWARDSHIP       
  39 
Protection of Human Subjects 
Ethical Standards 
Protection of human subjects was maintained through anonymous data collection for 
pre-intervention and post-intervention chart audits. Data collected from the EHR for patient 
characteristics included, age, gender, ethnicity, smoking status, and comorbidities. These data 
sets were password protected and did not contain specific patient identifiers. Data collected for 
provider characteristics were anonymous for inclusion within project data. As a component of 
the antibiotic stewardship program the tracking and reporting of antibiotic prescribing habits of 
providers was reported only to stakeholders, director of practice improvement and director of 
quality improvement, within the healthcare system for the determination of top performer status. 
Upon the completion of data analysis and reporting of the results all project data was securely 
shredded and destroyed.  
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CHAPTER 4 
FINDINGS 
 This EBP project was designed to determine the effect of a multi-faceted intervention for 
antibiotic stewardship for providers in the outpatient clinical setting to determine prescribing 
practices for antibiotic therapies for bronchitis. The compelling clinical question was: Will an 
outpatient antibiotic stewardship program increase provider awareness of inappropriate 
antibiotic prescribing for upper respiratory conditions specifically bronchitis thereby decreasing 
the number of inappropriate prescriptions written while encouraging patient awareness of the 
detrimental effects of the use of antibiotic therapy when not required?  
The project was conducted at a large network of community clinics in Northwest Indiana. 
Each individual facility has a varying number of providers, nurse practitioners and physicians. 
These providers offer services that cover care across the lifespan, urgent care services are also 
available. Implementation of this program was directed to providers with a planned approach at 
the monthly mandatory staff meeting at which all providers were required to attend. This 
approach included a PowerPoint® presentation, question and answer session, survey, and 
finally distribution of hard copies of EBP for antibiotic therapy for the most commonly diagnosed 
upper airway conditions that normally do not require antibiotic therapy. The patient portion of the 
outpatient antibiotic stewardship program included printed material in the form of a trifold from 
the Centers for Disease Control and Intervention (2018) “Be Antibiotics Aware” with the harms 
associated with using antibiotic therapy when not needed and the explanation of antibiotic 
resistance. These handouts for patients were distributed to clinic sites by the project leader for 
display in high patient traffic areas, exam rooms and lobby. Finally, bimonthly e-mail reminders, 
promoting antibiotic stewardship were sent to providers by the director of practice improvement.  
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Participants 
Size and Characteristics 
 Participants for this EBP project, a multifaceted antibiotic stewardship program, were the 
providers, staff, administrators, ancillary staff, and patients of a large multi-site northwest 
Indiana health care agency.  A total of 25 (N = 25) providers participated in the monthly 
mandatory staff meeting: 10 physicians, 11 nurse practitioners, and 4 licensed clinical social 
workers who provide behavioral health services for patients (see Figure 4.1) The ages ranged 
from 30-70 years (M = 46.9, SD =9.14). Within the group, 24% (n = 6) were men and 76% (n = 
19) were women. All providers were documented to have at least three years of clinical 
experience.  A total of 11 providers, 5 physicians and 6 nurse practitioners, completed the 
antibiotic stewardship survey. A total of five patients were offered the wait and see prescription 
(WASP). All WASP recipient patients were female, and ages ranged from 26 to 54 years (M = 
39.8, SD = 11.14).  
 A retrospective chart audit was conducted for the dates of November 1, 2017-January 
31, 2018 and included the diagnosis code J20.9, bronchitis. Patient characteristics included 
gender, ethnicity, age, date of service (DOS), chronic conditions, smoking status, provider seen, 
and antibiotic prescription given. The post intervention chart audit included the exact same 
parameters with the date range of November 1, 2018-January 31, 2019. Data collection pre and 
post-intervention was obtained with a random query of the EHR for the predetermined 
parameters and differing timeframes. Data collection revealed the age range for patients was 18 
-64 years, (M = 42.8, SD = 12.6) pre-intervention, and post intervention the age range of 19 - 64 
years (M = 42.7, SD = 12.4). Data collection further revealed that pre intervention, 64.4% of the 
patients seen were women and 35.6% were men (M = 1.35, SD = .479).  Post intervention data 
showed that 62.8% of patients seen were women and 37.2% were men (M = 1.37, SD = .484). 
Ethnicity data collection revealed pre intervention that 0.4% of patients identified as American 
Indian, 0.4% of patients identified as Asian, 17.6% of patients identified as Black/African 
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American, 0.4% identified as Hispanic, 0.2% identified as Hispanic or Latino, 0.6% identified as 
more than one race, 0.2% identified as Pacific Islander, 0.2% identified as Other Race, 14.6% 
Refused to Report/Unreported, and 69% identified as White/Caucasian. Post intervention 
results included American Indian, 0.3% identified as, 0.4% of patients identified as Asian, 18.7% 
identified as Black/African American, 0.8% identified as Hispanic, 0.04% identified as Hispanic 
or Latino, 0.4% identified as more than once race, 0.1% identified as Pacific Islander, 0.2% 
identified as Other Race, 12.4% Refused to Report/Unreported, and 71% identified as 
White/Caucasian. Based on independent samples t tests, ages of the two groups were not 
significantly different (t (2) = .561, p > .05). Based on chi square test of independence, the two 
groups were not significantly different for the characteristics of gender and ethnicity p >.05.    
Changes in Outcomes 
Statistical Testing 
Data analysis was completed using SPSS Version 25. Parametric tests were used to 
determine the difference in prescribing rates for diagnosis code J20.9, bronchitis. Statistical 
significance was established for all data at p <.05. Chi-square test of independence was 
calculated comparing prescribing rates. Descriptive statistics and frequencies were completed 
according to the predetermined parameters of demographic data for all patients (N = 500) 
included pre-intervention (n = 250) and post intervention (n = 250). Following data analysis, it 
was determined that two providers be removed from the sample due to not attending the 
intervention. This resulted in a new set of demographic data for all patients (N = 282), pre-
intervention (n = 130) and post intervention (n = 152). Independent sample t-tests and Chi 
square were used to determine pre and post-intervention patient characteristics, and physician 
and nurse practitioner antibiotic prescribing rates (Cronk, 2017). Pre-intervention and post 
intervention patients were included via random chart audit with the only determiner being a 
diagnosis of bronchitis J20.9. The chi-square test of independence is used to determine if two 
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variables are independent of each other (Cronk, 2017). Independent sample t-test utilizes the 
mean of two independent samples to determine if a relationship exists (Cronk, 2017). 
An independent-samples t-test was calculated comparing the mean score of patients 
who received an antibiotic and the mean score of patients who did not receive an antibiotic. No 
statistical difference was found (t (2) = .872, p <.05). The mean of the patients who received 
antibiotics (M = 1.50, SD = .501) was not significantly different from the mean of patients not 
receiving antibiotics (M = 1.47, SD = .503) An independent-samples t-test was calculated 
comparing the mean score of nurse practitioners (M = 1.16, SD = .372) prescribing antibiotics to 
the mean score of physicians prescribing (M = 1.15, SD = .362) antibiotics. No significant 
statistical difference was found (t (2) = 0.283, p < .05). An independent-samples t-test was 
calculated comparing the mean score of pre-intervention antibiotic prescribing (M =1.63, SD 
= .484) to post intervention antibiotic prescribing (M =1.59, SD = .493). No statistical difference 
was found (t (2) = 0.72, p <.05). Analysis of the patients who received the WASP showed 20% 
lost to attrition, 60% did not fill the prescription (felt better), and 20% did fill the prescription (felt 
worse).  
Significance 
No statistical significance was evident following Chi square test of independence for pre 
and post-intervention data comparing antibiotic prescribing rates. No significant relationship was 
found (X2 (1) = .647, p <.05). The intervention does not appear to have had an impact on 
prescribers’ habits of whether to provide an antibiotic prescription for bronchitis. Pre-intervention 
analysis revealed 83.6% of patients received antibiotics with post intervention analysis revealing 
85.2% receiving antibiotics. No antibiotics were given to 16.4% of the pre-intervention patients 
and 14.8% of the patients’ post-intervention did not receive an antibiotic. A Chi square test of 
independence was calculated comparing smoking status and receiving an antibiotic 
prescription. A significant interaction was found (X2 (1) = 3.201, p < .05). Smokers were more 
likely to receive a prescription for antibiotics than non-smokers. A chi square test of 
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independence was calculated to determine a relationship between gender and antibiotic 
prescribing. No significant relationship was found between gender and receiving an antibiotic 
prescription (X2 (1) = .540, p < .05). Gender and antibiotic prescribing appeared to be 
independent of one another. A chi square test of independence was calculated comparing 
ethnicity and antibiotic prescription relationship. No significant relationship was found (X2 (1) 
=.320, p < .05). Ethnicity and receiving an antibiotic prescription appear to be unrelated. A chi 
square test of independence was calculated comparing comorbidities and antibiotic prescribing. 
No significant relationship was found (X2 (1) =.669, p < .05). Comorbid conditions and receiving 
an antibiotic prescription appear to be unassociated.  
Proportionally, more patients were seen during the identified timeframes, November-
January 2018-2019, by physicians’ pre-intervention at 62% and post intervention at 58.8% than 
nurse practitioners who were at 37% pre-intervention and at 41% post intervention respectively. 
Influenced by the antibiotic stewardship program nurse practitioners prescribing antibiotics 
decreased from 85% pre intervention to 82.5% post-intervention. An increase in antibiotic 
prescribing was shown for physicians from pre intervention 82% to post intervention 87%. 
Individual provider prescribing results pre and post-intervention were made available to the 
stakeholders, directors of practice improvement and quality improvement, for their dissemination 
and conclusion within the community health care organization. 
 Survey results yielded positive responses congruent with attendance at the antibiotic 
stewardship intervention presentation. For the question of has antibiotic overuse contributed to 
the problem of increased drug resistance, 100% of respondents replied true. For the question of 
for acute cough lasting for 1 week, antibiotics are indicated 80% of respondents replied false 
with 20% replying true. For the question of to decrease antibiotic use, delayed prescribing is an 
appropriate technique for providers to utilize 90% of respondents replied true with 10% replying 
false. For the question of bronchitis or acute cough may last up to three weeks 100% of 
respondents replied true (see Figure 4.2). For the question of how often your patients request 
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antibiotics unnecessarily 90.9% of respondents replied frequently, to somewhat frequently with 
9.1% replying neutral (see Figure 4.3). For the question of how likely are you to incorporate 
antibiotic education into your clinic visits with patients 72.73% of respondents replied extremely 
likely with 18.18% responding likely and 9.09% as neutral (see Figure 4.4). For the question of 
how helpful is an antibiotic stewardship program promoting best practice, 90.91% of 
respondents replied extremely helpful to helpful with 9.09% as neutral. For the question of how 
likely you are to incorporate delayed prescribing (WASP) into your practice, respondents replied 
extremely likely to likely 81.82% with 9.09% as neutral (see Figure 4.5). For the question of how 
important you would say antibiotic education is for the public, all respondents 100% replied 
extremely to very to somewhat important (see Figure 4.6). 
Figure 4.1 
 
37%
46%
17%
PROVIDERS ATTENDING THE INTERVENTION
Physicians Nurse Practitioners Licensed Clinical Social Workers
ANTIBIOTIC STEWARDSHIP       
  46 
Figure 4.2 
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Figure 4.3 
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Figure 4.5 
 
Figure 4.6
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CHAPTER 5 
DISCUSSION 
This evidence-based practice project was designed to answer the compelling clinical 
question of: “will an outpatient antibiotic stewardship program increase provider awareness of 
inappropriate antibiotic prescribing for upper respiratory conditions specifically bronchitis, 
thereby decreasing the number of inappropriate prescriptions written while encouraging patient 
awareness of the detrimental effects of the use of antibiotic therapy when not required?” This 
project, which was implemented at a large multi-site community health care organization in 
Northwest Indiana. The focus was on the determination of a multifaceted intervention, which 
included provider information session, visual reminders, utilization of change champions and 
survey results which would influence providers to decrease the number of unnecessary 
prescriptions for bronchitis. Project findings, including limitations and successes will be 
disseminated in this chapter. Theoretical and EBP frameworks utilized for this project as well as 
implications for future projects similar to this project will also be discussed. 
Explanation of Findings 
Initial project evaluation for this EBP project, with documented findings, was designed to 
answer the primary clinical question concerned with prescribing for bronchitis. Data for 
secondary outcomes to determine if there was a difference between prescribing rates for nurse 
practitioners and physicians as well as results from the distribution of the wait and see 
prescription (WASP) were explored.  
 Prior to the intervention for providers, the organization had a policy change. Previously, 
providers were required to meet every month for a staff meeting. All staff members would 
convene at a predetermined location for approximately one hour. The provider’s clinic schedules 
were adjusted to meet this demand. For the month of the EBP implementation September 2018, 
administrators required providers to attend the monthly mandatory staff meeting via 
teleconference. This scenario removed the initial one-to-one contact between providers and the 
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project leader. For the teleconference 10 physicians, 11 nurse practitioners, and four licensed 
clinical social workers attended the antibiotic stewardship intervention presentation. The 
teleconference included the PowerPoint® presentation which was emailed to all providers prior 
to the appointed day in September. This allowed providers to follow along while the intervention 
was introduced and explained. One week following the presentation, the project leader and 
director of practice improvement travelled to all locations. Instructions with explanations of the 
antibiotic stewardship program were made by the director of practice improvement. The project 
leader reintroduced the implementation requirements, as well as distributed guidelines, posters, 
patient information brochures, and paper surveys. Approximately two weeks following this step, 
one survey was returned. 
       Another change that took place at the organization was the acquisition of a new medical 
director. During this phase, the project leader updated the provider survey to an electronic 
version for distribution to all providers within the healthcare organization. The medical director 
was briefed on the project, supported the project, and became a champion by distributing the 
new electronic version of the survey to all providers within the healthcare organization via e-
mail. The project leader determined a one-month timeline for survey completion. The project 
leader also offered the incentive of a chance to win one of four gift cards. Following the 
predetermined timeframe for survey completion and closure of the electronic source, providers 
who completed the survey were randomly drawn by the director of quality improvement. 
Surveys were completed by 11 providers within the healthcare organization. Gift card 
distribution was completed by project leader and director of quality improvement for the 
incentive.  
 For the primary clinical question: Is there a difference in the prescribing rate for providers 
for bronchitis pre-intervention and post intervention? The main outcome for this project was 
examined in detail with a focused approach. Ideally, there should be no prescriptions given for 
bronchitis according to CDC guidelines (CDC, 2016). Pre-intervention data were obtained with a 
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retrospective chart audit for the months of November 2017 to January 2018. The criterion for 
inclusion was the diagnosis of bronchitis which is the ICD-10 code of J20.9. Post intervention 
chart audit was conducted in February of 2019 for the corresponding dates of November 2018 
to January 2019. No statistical significance was determined following chi square data analysis. 
Rates of prescribing for all providers remained consistent post intervention, (X2(1) =. 647, p 
<.05).  
When examined separately by provider, findings indicated that nurse practitioners 
prescribing rates showed an improvement in not prescribing an antibiotic prescription for 
bronchitis: 85% pre-intervention and 82.3% post-intervention. Physicians, on the other hand, 
showed an increase in the number of prescribing antibiotics, with 82% pre-intervention to 87% 
post intervention.  
 Additional outcomes evaluated were based on pre and post-intervention data to 
determine if there was a significant difference in providers prescribing habits among nurse 
practitioners and physicians. An independent-samples t-test was calculated comparing the 
mean score of nurse practitioners to the mean score of physicians. No significant statistical 
difference was found (t (2) = 0.283, p > .05). Ultimately from the analysis, it was determined that 
physicians treated more patients during the required timeframes than nurse practitioners. 
Patients treated by physician’s were 62% at pre-intervention and 58.8 % post intervention with 
nurse practitioners treating patients 37% at pre-intervention and 41% at post intervention 
respectively. Due the increase in number of patients being treated by physicians the data 
analysis reports increased findings for the physician group. If, perhaps, more patients were 
treated by nurse practitioners, the data analysis result may have shown an even greater 
statistical significance in the decrease in prescribing of antibiotic therapies. From the data 
analysis this could be expected. Data analysis of the results of the wait-and-see-prescription 
(WASP) for patients demonstrated 20% were lost to attrition; 60% did not fill the prescription 
(felt better) which was the aim of this method; and 20% did fill the prescription (felt worse). 
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Provider perception of patient demand and expectations may be further explored with future 
projects. This future project might involve provider and patient surveys concerning antibiotic 
prescribing and satisfaction with the outcomes of the visit. Expectations for patients and 
providers should be explored. (IDSA, 2016; Keller, Tamma, Cosgrove, Miller, Sateia, Szymczak, 
Gurses, Linder, 2018; Meeker et al., 2015; Zetts, Stoesz, Smith, & Hyun, 2018). The CDC 
(2016) reports that ongoing communication skills training for providers will improve the patient 
provider experience. Patient expectation my further be improved by the addition of symptomatic 
treatment regimens, from providers, such as cough suppressants to help with sleep, and 
decongestants to decrease congestion, as well as chicken soup and warm liquids. These 
treatments may help to manage patient expectations and avoid disappointment with the visit 
(Keller et al., 2018; Meeker et al., 2015). 
Provider survey results concerning knowledge about antibiotic stewardship yielded 
responses congruent with the intervention presentation. The responses related to antibiotic 
overuse, delayed prescribing, and antibiotic education for the public were correct and 
corresponded with best practice (CDC, 2016; Drekonja et al., 2015). Providers agreed that 
overuse of antibiotics has led to an increase in drug resistance. Providers also agreed that 
delayed prescribing is an appropriate technique to use in the clinical setting, and antibiotic 
education is extremely important for patients. However, while the physicians and nurse 
practitioners at this community health organization were knowledgeable about correct 
prescribing guidelines for bronchitis, the results showed providers did, in fact, prescribe 
antibiotics for bronchitis. Keller et al. (2018) and IDSA (2016) described providers who attended 
evidence-based education for antibiotic stewardship focused on upper respiratory conditions 
showed a decrease in antibiotic prescribing over a 30-month period. The promotion of the 
antibiotic stewardship program annually may show a decrease in prescribing in the upcoming 
years. The three-month time frame may have not been a long enough amount of time to 
determine accurate provider prescribing practices and support a significant decrease and 
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change in antibiotic prescribing. We cannot determine if providers disregarded the seriousness 
of the threat of antimicrobial resistance nor disregarded the promotion of judicious antibiotic 
prescribing. (Drekonja et al., 2015; CDC, 2016; Arnold & Straus, 2009; Schmidt, Spencer, & 
Davidson, 2018; Zetts et al., 2018). Further, we do not know if providers related the problem of 
over prescribing to other provider practices not their own (Zetts, et al., 2018; Fiore, et al., 2017). 
The yearly antibiotic stewardship program for providers attending the education 
sessions, as well as feedback, may further increase the reduction in prescribing antibiotics for 
bronchitis, which was sustainable for two to three years (Keller et al., 2018). Provider 
commitment in the form of posters, letters, and pictures will benefit from being updated annually 
to provide visual confirmation for patients of the commitment from providers for responsible 
prescribing. Literature supports the use of these techniques to decrease inappropriate 
prescribing for bronchitis (Meeker et al., 2015; Zetts et al., 2018). EMR support should be 
included for providers in the form of a prompt (clinical decision support) when initiating the 
diagnosis code for bronchitis, J20.9, for visual reminder of no antibiotic required to decrease 
inappropriate prescribing (CDC; Sanchez, Guillermo V; Dutra-Fleming, Katherine E; Roberts, 
Rebecca M; Hicks, Lauri A, 2016; Keller et al., 2018).  
Provider prescribing was disseminated by the stakeholders within the community 
healthcare setting with individual provider results reported by the quality improvement 
department. As reported to the project leader, providers receipt of results was uneventful with 
no response currently. This may be possibly due to results being shared with individual 
providers via e-mail, as well as the short timeframe for initiation of the program. Keller et al. 
(2018) found that for providers with high prescribing rates and who received data about their 
habits, this information “did not impact antibiotic prescribing over 2 years” (p.424). CDC (2016), 
IDSA (2016), Drekonja et al. (2015), Keller et al. (2018), Schmidt et al. (2018) agree that this 
undesirable effect was possibly due to providers receiving written communication about 
prescribing habits; however, these providers have currently received results of prescribing via 
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electronic communication only. Upcoming results related to a substantial decrease in 
inappropriate antibiotic prescribing was individualized feedback for providers regarding their 
individual antibiotic prescribing rates which may show a decrease in the future for this 
community healthcare facility. 
Evaluation of Applicability of Theoretical and EBP Frameworks 
For the application of the theoretical and EBP frameworks to the evidence-based 
practice project, the first step was the determination of whether an antibiotic stewardship 
program was in place. This EBP project utilized Lewin’s Planned Theory of Change (Lewin, 
1947) for the theoretical framework and the Advancing Research and Clinical Practice through 
Close Collaboration (ARCC) model (Melnyk & Fineout-Overholt, 2015) for the evidence-based 
practice framework. These theories will be discussed in relation to the EBP project. 
Theoretical Framework 
The theoretical framework chosen was Lewin’s Theory of Planned Change. According to 
the Lewin theory, when observing a situation, leaders must understand that there will be a 
“series of forces working in different directions” (Lewin, 1947, p. 341). Within the organizational 
setting, there will be forces eager to change and forces determined to maintain the current 
situation. Lewin’s method hypothesizes that behavior is a role of the group environment or field 
(Lewin, 1947; Borkowski, 2016). Individual provider characteristics determine obstacles to the 
success of the project. Guidelines are intended to supplement providers experience and 
knowledge. Guidelines are diagnosis specific, but not necessarily patient specific. Literature is 
clearly supported by CDC, WHO, and National Physician Alliance who acknowledge that in 
clinical practice being a good steward is the ability/opportunity to decrease the prescription use 
of antibiotics for bronchitis, which also happens to be one of the top five applications of antibiotic 
stewardship (Holmes, Struwe, & Waltman, 2018). As evidenced by the data analysis, the 
diagnosis of bronchitis may have warranted a prescription from providers based on individual 
patient presentations. A female patient 28 years, with a BMI of 25 with no chronic conditions will 
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be treated differently than a female 63 years with a BMI of 58 with historical diagnosis of COPD. 
As will there be a difference of antibiotic treatment regimen between smokers and non-smokers 
(Steinberg, Akincigil, Jung Kim, Shallis, Delnevo, 2016). Providers replied consistently with best 
practice to survey responses but ultimately survey responses may not be applicable in the 
clinical setting due to individual patient characteristics and circumstances.   
Freeze, change, unfreeze is a compelling concept for completion of this intervention. 
This intervention led to a new yearly policy/protocol (see Appendix E) for providers which will 
involve an education module with the PowerPoint® presentation provided by the project leader. 
The presentation incorporates the survey questions to keep current with CDC recommendations 
and possible requirement from the Centers for Medicare and Medicaid (CMS).  
The freeze involved a new situation, the implementation of an antibiotic stewardship 
program new to the agency. The change involved provider participation in the teleconference 
meeting as well as survey completion and refreeze was the new normal of a yearly antibiotic 
stewardship requirement for providers to complete. Providers, staff, and administrators were 
eager and willing to participate in the intervention and were willing to comment in positive 
language to the project leader. Comments received included, “great information”, “good 
presentation”, “helpful”, and “the paperwork is colorful”. But even though they responded as 
anticipated about antibiotic stewardship, the providers did not decrease the amount of 
antibiotics they prescribed for the diagnosis of bronchitis. However, from the data analysis, 
smoking status resulted in an increase in prescribing antibiotics, which from the literature basis, 
is an expected finding (Steinberg et al., 2016)  
 To implement the proposed change (goal), the forces eager and willing to change must 
be increased; these are the driving forces (Lewin, 1947; Borkowski, 2016). Following 
dissemination of the project, recruitment of more champions may have been beneficial to the 
success of the project. Individual clinic access was maintained by the project leader; however, 
during the process, it was difficult to reinforce and promote the project to providers within the 
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demanding clinical setting. Providers were extremely busy, ancillary staff were extremely busy, 
and patients were waiting to be seen. There were no restraining forces identified, but for the 
status quo to be decreased, an individual champion at each facility may have contributed to an 
increased success of the project. A goal that was achieved is the accomplishment of a yearly 
antibiotic stewardship policy/protocol for this healthcare facility. Antibiotic stewardship programs 
are currently required for hospital and long-term care facilities that receive funds from the 
Centers for Medicare and Medicaid (CMS). This project led to a sustainable change with the 
introduction of a yearly antibiotic stewardship intervention for providers at the organization which 
is sustainable by the facility and is the new normal. 
 Strengths of the Lewin theory included ease of use, realistic, and provided a straight-
forward plan of three steps for change. The three steps provided a basic strategy of unfreeze, 
change, refreeze to implement the change. These steps provided guidance with this EBP 
project acknowledging forces for and against the change while allowing the project leader to 
identify issues acting for or against change. This theory is time-tested and applicable to the 
outpatient clinical setting. The top-down approach was effective for the implementation of this 
EBP project which included strong support from stakeholders. 
Outwardly there appeared to be no obstacles to change, but from the data analysis, it is 
evident this theory may have been too simplistic. The three-step approach was not realistic nor 
generalizable. Providers with years of knowledge and experience did make the final 
determination of whether their patients required antibiotic therapies for bronchitis. EBP 
guidelines are intended to guide practice not replace clinical judgment. Change is multifaceted 
and unpredictable; therefore, in the clinical setting it was not possible to frame the project in a 
three-step scenario. Ultimately it was difficult to enact a change during a three-month timeframe 
for such an extensively constructed, provider and patient specific scenario.  
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EBP Framework 
 The EBP model chosen for use with this project was the ARCC Model.  ARCC stands for 
Advancing Research and Clinical Practice through Close Collaboration (Melnyk & Fineout-
Overholt, 2015). This model strictly focuses on the implementation of best evidence-based 
practice along with promotion of sustainability system wide. This model has five steps. Step one 
is the assessment of the organization, the culture, and readiness for clinic wide change 
implementation. Step two is the recognition of strengths and limitations of evidence-based 
practice within the organization. Step three is the identification of evidence-based practice 
advisors and guides. Step four is the implementation of evidence into practice, and step five is 
the evaluation of determined outcomes that have resulted from the practice change (Melnyk & 
Fineout-Overholt, 2015; Schaffer, Sandau & Lee, 2012). Step five included project evaluation 
with outcomes disseminated. 
The ARCC model strictly focused on the implementation of best evidence-based practice 
along with promotion of sustainability system wide. Consistent with the model, EBP guidelines 
were distributed following the formal intervention meeting with providers. As the ARCC model 
highlights, organizational culture and the circumstances that support EBP were utilized in the 
form of monthly e-mail reminders to providers promoting the antibiotic stewardship intervention.  
Although this model clearly stresses organizational procedures to strengthen EBP within direct 
patient care, ultimately the decision-making process at the point of care must include provider 
expertise along with patient preference (Melnyk & Fineout-Overholt, 2015). From the extensive 
data analysis, it was concluded that individual provider judgement and knowledge determined 
whether antibiotic stewardship clinical guidelines were followed. 
 The emphasis of the ARCC model is on organizational usage. For this project and step 
one of the model, the identification of organizational culture was determined by the project 
leader. There was no formal antibiotic stewardship program in place, now the organization has 
an antibiotic stewardship protocol based directly on current CDC guidelines. The strengths of 
ANTIBIOTIC STEWARDSHIP       
  58 
the organization are the administrative characteristics of an inviting and approachable attitude, 
as well as, progressive, forward thinking. This thinking acknowledges provider, patient, and 
community interests. This healthcare facility presented with a willingness to serve as a clinical 
site for project implementation, with the benefit of a sustainable organizational change in the 
form of a protocol for the yearly management of an antibiotic stewardship program. 
Administrative support was crucial for clinic wide implementation and a positive response was 
received from all stakeholders.  
During step two, the strengths and limitations of the application of evidence-based 
practice was examined. EBP is intended to be a guide for providers, EBP is intended to 
complement provider experience and knowledge base concerning individual patient population 
and characteristics, not supersede it. Guidelines are intended to supplement not replace 
provider knowledge and experience. During step three of the model, EBP mentors were 
identified, including project leader, and directors of practice improvement and quality 
improvement. As determined by the project leader, an increase in champions/mentors was 
needed for successful implementation outcomes. The project leader determined that the project 
would have benefited from recruiting an individual from each site to increase facilitation of the 
EBP project. Step four of the model, implementation of EBP guidelines was established by the 
participation of providers in the antibiotic stewardship intervention program, with distribution of 
current CDC guidelines to all providers, along with bi-monthly reminders for the promotion of 
antibiotic stewardship. Step five, the evaluation of the project was completed by the project 
leader with strengths and limitations discussed.  
Strengths and Limitations of the EBP Project 
Strengths 
Strengths for the EBP project include the applicability of the ARCC model and Lewin’s 
Theory of planned change to the implementation of this project. These frameworks provided a 
comprehensive, thorough guide to the determination of characteristics required for the 
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successful intervention and implementation of the EBP project. This EBP project was based on 
the extensive literature review with implementation of the intervention taken from current 
disseminated research. Currently, the healthcare facility with multiple locations and multiple 
providers will now have access to, and the opportunity intended for, a yearly roll-out of antibiotic 
stewardship activities and literature. This yearly intervention will include provider and patient 
information. Also included with the intervention, from the data analysis, the opportunity for 
facility directors to statistically determine and visually understand “top provider” status with the 
reporting of individual provider prescribing habits for bronchitis. 
Limitations 
Limitations of this EBP project were the simplistic approach to antibiotic prescribing 
adopted by the project leader. Guidelines are diagnosis specific, but not necessarily patient 
specific. For example, a female patient 28 years, with a BMI of 25 with no chronic conditions will 
be treated differently than a female 63 years with a BMI of 58 with historical diagnosis of COPD. 
As will a 35-year-old male with current diagnosis of HIV, these individual patients will be treated 
appropriately by providers due to comorbid or chronic conditions (CDC, 2016). Antibiotic 
prescribing is based on several factors, chronic health conditions, smoking status, and BMI for 
example, not only diagnosis (CDC, 2016; Steinberg et al., 2016). EBP includes utilization of 
guidelines from nationally recognized professional organizations, with interventions based on 
provider, patient and facility specifics. This EBP project intervention included the PowerPoint® 
presentation, survey, and bimonthly e-mail reminders. This process was applicable, however, 
the extensive approach to the project may have required a more focused intent and method. 
The environment for this EBP project was applicable to the intervention, however, a more 
intensive and concentrated intervention may have yielded statistically significant results. A 
future project recommendation could include a “one clinic, one provider or one group of 
providers” focus with the intervention presented in a face-to-face format. Also, for future projects 
it is recommended that a focused intervention promoting the WASP be undertaken. Additionally, 
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a time-frame determiner of Winter only months (January-March) may also have yielded 
statistically insignificant results. An increase in the timeframe from three months to six months 
or greater may have yielded statistically significant results (Keller et al. 2018; IDSA 2016). 
 
Implications for the Future 
Practice 
Although the data analysis yielded no statistical significance within the project sample, it 
was determined that nurse practitioners remained consistent and showed an improvement for 
not prescribing antibiotics pre intervention through post-intervention. The data analysis 
determined that the use of an antibiotic stewardship intervention did not decrease the number of 
prescriptions written for bronchitis for physicians. These outcome findings conclude that the 
implementation of the intervention had no effect on providers prescribing rates for bronchitis. It 
is not known why the providers did not change their prescribing practices. Increased rates of 
prescribing may be due to the contributing factors of patient expectation, patient and provider 
unawareness of antibiotic resistance, and an increased number of patients who smoke, and a 
lack of knowledge of the serious consequences of antimicrobial resistant microorganisms (CDC, 
2016; Steinberg et al., 2016). Obstacles to correct antibiotic prescribing may have been a high 
volume of patients with increased pressure for expedited visits, and unsatisfied patients if 
antibiotic prescriptions are not given (CDC, 2016; Drekonja et al., 2015).  
The significant practice findings of this EBP project include the development of a 
sustainable facility-wide protocol for antibiotic stewardship to meet the future possibly likely 
requirement by CMS. This yearly intervention for providers will reintroduce the topic annually, as 
well as offer opportunities for providers to earn “top performer” status. Stakeholders and facility 
directors will have ease of use with the implementation of the intervention from materials 
provided by the project leader. This intervention is based on current literature, CDC guidelines, 
and may not require a revision for quite some time. Antibiotic stewardship will remain at the 
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forefront of patient care due to the increasing number of antimicrobial resistant microorganisms. 
Sharing the results of this project with the providers may provide them with a view of their 
practice. While all providers agreed that antibiotic stewardship was needed, the providers did 
not follow clinical guidelines for practice for bronchitis treatment. Seeing these individual 
provider results may impact their future practice as they are able to reflect on their own EBP 
care. For future project use, the focused approach would include a sustained facility wide 
education session with implementation of the wait and see prescription. 
Theory 
The results of this EBP project were not consistent with past results from the literature 
and successes with implementation. Although literature support for the project was strong, 
results were fewer than expected. Lewin’s Theory of planned change provided an exceptional 
initial framework for the determination of inclusion for the project intervention. The ease of use 
and minimal steps offer an applicable way to determine inclusion criteria for the intervention. 
Lewin’s Theory did not address the fluidity of change, and the results of provider knowledge and 
experience. Lewin’s Theory also emphasizes the forces for and against change. With this EBP 
project the determination was made that individual patient characteristics and provider decisions 
guided antibiotic prescribing, not the change of promoting EBP guidelines.  
Of the providers surveyed, all agreed with all components of the antibiotic stewardship 
intervention, however guidelines did not replace clinical judgements. The ARCC model provided 
a valuable tool for the applicability of EBP and the promotion of a sustainable facility wide 
initiative. This model allowed for the assessment of the organization and culture. While 
readiness to change may not have been appropriate, due to individual provider characteristics, 
the top down approach provided a sustainable facility protocol for antibiotic stewardship 
intervention. The recognition of strengths and limitations of EBP was evident with the 
development of this project. Although the intervention is supported by the literature, an increase 
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in number of champions may have been beneficial. This model is well-suited to this project, but 
it has been determined the project focus was ultimately to extensive.  
Research 
Implications for future research based on the results of this EBP project include a 
comprehensive approach to antibiotic stewardship with a determined focus on provider, patient 
and community perceptions. Additional research should be conducted to focus on the WASP 
wait and see prescription. Current literature supported recommendations include the 
implementation of the antibiotic stewardship program, however, research must include the 
provision for individual provider clinical judgement and experience. An additional component 
may be the determination of time of day and day of week that the providers distributed the 
prescriptions for antibiotics. The project leader was witness to clinical judgement that included a 
late Friday appointment where the patient did not fit the criteria of requiring an antibiotic but was 
prescribed one based on, it being the beginning of the weekend. The rationale from the provider 
was that of, “this patient will go to urgent care or the emergency department for the prescription 
if I do not provide it, and that is a waste of resources and dollars”.  
Education 
The intervention presented to providers was based on the CDC guidelines for antibiotic 
stewardship. This PowerPoint® presentation was completed within the required meeting 
timeframe, 20 minutes, and the providers were offered the opportunity to comment. Ideally, if 
the survey had been distributed immediately following the presentation in a face-to-face format, 
more providers may have participated. Future implications for this project would preferably 
include a “lunch and learn” for providers within the clinic setting to increase participation with 
survey completion and reporting of results.   
 Antibiotic stewardship education must be on-going. Facilities, providers, and patients 
must accept responsibility for promoting efficacious use of antibiotics. The world-wide crisis of 
antimicrobial resistance will not go away and may increase. Although this EBP project 
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promoting best practice did not yield results consistent with the literature, this facility that serves 
a large diverse population will have the opportunity to promote antibiotic stewardship yearly. 
Conclusion 
Conclusions of this EBP project though varied, do support an antibiotic stewardship 
policy/protocol for providers in the outpatient setting. While the predetermined outcomes of this 
EBP project did not provide statistical significance to support the evidence that an antibiotic 
stewardship intervention will decrease the number of prescriptions given for bronchitis, the 
project did, however, support the use of the intervention for the promotion of education for 
providers concerning antibiotic mis/overuse with positive survey results and encouraged 
providers to offer the wait and see prescription if the individual patient situation warrants. Future 
projects will benefit from the analysis of data for this individual project by offering results 
consistent with an extensive and conceivably too simplistic approach to antibiotic prescribing for 
bronchitis in the outpatient clinical setting. Literature results show that a much longer timeframe 
be measured for successes with a decrease in prescribing of antibiotics for bronchitis. The 
reported timeframe appears to have been too brief. Future projects may also attempt to 
determine if time of day or day of week have an impact on prescribing antibiotics for bronchitis.  
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Appendix A 
Literature Search Results 
 
Database 
 
Key Terms Limiters Date Range Results Reviewed/Accepted 
CINAHL Antibiotic, 
antimicrobial, 
stewardship, 
sinusitis, 
upper 
respiratory, 
systematic 
review, 
guidelines, 
prescribe, 
prescriber, 
therapeutic, 
use, pattern, 
outpatient, 
ambulatory 
English 
Language 
Scholarly-
Peer 
Reviewed 
2014-
Present 
17 12/3 
Cochrane Antibiotic, 
antimicrobial, 
stewardship, 
sinusitis, 
upper 
respiratory, 
systematic 
review, 
guidelines, 
prescribe, 
prescriber, 
therapeutic, 
use, pattern, 
outpatient, 
ambulatory 
English 
Language 
Scholarly-
Peer 
Reviewed 
2014-
Present 
1 1/0 
Johanna 
Briggs Institute 
Antibiotic, 
antimicrobial, 
stewardship, 
sinusitis, 
upper 
respiratory, 
systematic 
review, 
guidelines, 
prescribe, 
prescriber, 
therapeutic, 
English 
Language 
Scholarly-
Peer 
Reviewed 
2014-
Present 
110 15/0 
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Database 
 
Key Terms Limiters Date Range Results Reviewed/Accepted 
use, pattern, 
outpatient, 
ambulatory 
MEDLINE Antibiotic, 
antimicrobial, 
stewardship, 
sinusitis, 
upper 
respiratory, 
systematic 
review, 
guidelines, 
prescribe, 
prescriber, 
therapeutic, 
use, pattern, 
outpatient, 
ambulatory 
English 
Language 
Scholarly-
Peer 
Reviewed 
2014-
Present 
40 25/2 
National 
Guideline 
Clearinghouse 
Antibiotic, 
antimicrobial, 
stewardship, 
sinusitis, 
upper 
respiratory, 
systematic 
review, 
guidelines, 
prescribe, 
prescriber, 
therapeutic, 
use, pattern, 
outpatient, 
ambulatory 
English 
Language 
Scholarly-
Peer 
Reviewed 
2014-
Present 
1 1/0 
AHRQ/CDC Antibiotic, 
antimicrobial, 
stewardship,  
NA 2014-
Present 
2 1/1 
ProQuest Antibiotic, 
antimicrobial, 
stewardship, 
sinusitis, 
upper 
respiratory, 
systematic 
review, 
guidelines, 
prescribe, 
prescriber, 
therapeutic, 
English 
Language 
Scholarly-
Peer 
Reviewed 
2014-
Present 
147 30/1 
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Database 
 
Key Terms Limiters Date Range Results Reviewed/Accepted 
use, pattern, 
outpatient, 
ambulatory 
PubMed Antibiotic, 
antimicrobial, 
stewardship, 
sinusitis, 
upper 
respiratory, 
systematic 
review, 
guidelines, 
prescribe, 
prescriber, 
therapeutic, 
use, pattern, 
outpatient, 
ambulatory 
English 
Language 
Scholarly-
Peer 
Reviewed 
2014-
Present 
31 15/1 
Hand Search Citation 
Chase 
 2014-
Present 
2 2/0 
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Appendix B 
Literature Synthesis 
Antibiotic Stewardship in the Outpatient Setting 
 
 
Citation (APA) Purpose Intervention Design Outcome LOE 
Quality 
Barlam, Tamar F; 
Cosgrove, Sara E; 
Abbo, Lilian M; 
MacDougall, Conan; 
Schuetz, Audrey N; 
Septimus, Edward J; 
Srinivasan, Arjun; 
Dellit, Timothy H; 
Falch-Yetter, Yngve T; 
Fishman, Neil O; 
Hamilton, Cindy W; 
Jenkins, Timothy C; 
Lipsett, Pamela A. 
(2016). Implementing 
an Antibiotic 
Stewardship Program: 
Guidelines by the 
Infectious Diseases 
Society of America 
and the Society for 
Healthcare 
Epidemiology of 
America. Boston: 
Oxford University 
Press. 
 
Clinical guideline 
for the 
implementation of 
an antibiotic 
stewardship 
program. 
Expert panel developed 
the guideline by including 
a systematic review of 
the strength of 
recommendation and 
quality of evidence via 
the GRADE system. 
Guideline The use of evidence based best 
practice guidelines for the treatment of 
illness will lead to best outcomes and 
help to decrease antimicrobial 
resistance.  Each clinical site must 
determine what approach is best for the 
implementation of an antibiotic 
stewardship program.  Interventions 
must be multifaceted, communication, 
audit & feedback, and EHR support at 
time of prescribing.  Recommendation 
of drug, dose and duration of treatment 
be standardized to shortest amount of 
time, and specific to patient. 
Level I 
Good 
CDC; Sanchez, 
Guillermo V; Dutra-
Clinical guideline 
for the 
Consolidation of 
evidence-based antibiotic 
Guideline Provides a framework for best evidence 
for practice for improving antibiotic 
Level I 
Good 
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Citation (APA) Purpose Intervention Design Outcome LOE 
Quality 
Fleming, Katherine E; 
Roberts, Rebecca M; 
Hicks, Lauri A. (2016). 
Core Elements of 
Outpatient Antibiotic 
Stewardship. Division 
of Healthcare Quality 
Promotion, CDC, U. S. 
Department of Health 
and Human Services. 
Atlanta: Center for 
Surveillance, 
Epidemiology, and 
Laboratory Services, 
Centers for Disease 
Control and 
Prevention (CDC). 
Retrieved 2018 
 
implementation of 
an antibiotic 
stewardship 
program in the 
outpatient setting. 
stewardship programs 
and to expand on best 
practices for antibiotic 
stewardship for hospitals 
and long-term care 
facilities.  Narrative 
review including 5 
systematic reviews from 
2015-2016.  Subject 
matter experts were 
identified for their 
expertise.  These experts 
provided specific 
feedback on the 
feasibility, acceptability, 
recommended 
supplementary material 
and the potential to 
promote antibiotic 
stewardship that is 
effective for improving 
antibiotic prescribing. 
prescribing in the outpatient setting.  
Consistent effort on the part of the 
health care system is needed to 
achieve best outcomes.  The outpatient 
clinic setting must develop an antibiotic 
stewardship program that is provider, 
patient, and clinic specific.   
Drekonja, D. M., 
Filice, G. A., Greer, 
N., Olson, A., 
MacDonald, R., Rutks, 
I., & Wilt, T. J. (2015). 
Antimicrobial 
Stewardship in 
Outpatient Settings: A 
Systematic Review. 
Infection Control & 
Hospital 
Evaluation of the 
effect of an 
antibiotic 
stewardship 
program in the 
outpatient setting. 
Identified studies with 
evidence that antibiotic 
stewardship programs 
that incorporate 
communications and 
PCT are medium 
strength.  For antibiotic 
stewardship programs to 
be effective the approach 
must be multifaceted. 
Systematic 
review.   
A multifaceted approach (provider & 
patient education, audit & feedback, 
clinical guidelines, delayed prescribing, 
communication training and EHR 
prompts) to antibiotic stewardship 
programs was associated with 
decreased inappropriate antibiotic 
prescribing. No evidence of harm or 
high cost were shown, but they were 
not collectively assessed.   
Level I 
Good 
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Citation (APA) Purpose Intervention Design Outcome LOE 
Quality 
Epidemiology, 141-
152. 
 
Keller, S. C., Tamma, 
P. D., Cosgrove, S. E., 
Miller, M. A., Sateia, 
H., Szymczak, J., . . . 
Linder, J. A. (2018). 
Ambulatory Antibiotic 
Stewardship through a 
Human Factors 
Engineering 
Approach: A 
Systematic Review. 
Journal of the 
American Board of 
Family Medicine, 
31(3), 417-430. 
doi:10.3122/jabfm.201
8.03.170225 
 
The identification 
of interventions 
and studies of 
antibiotic 
stewardship.   
Interventions focuses on 
clinical decision support 
& PCT, provider 
education, audit & 
feedback, delayed 
prescribing, and 
commitment posters. 
Systematic 
Review 
A positive impact on antibiotic 
stewardship were provider 
communications training, education for 
providers and patients, audit and 
feedback, and signed clinic posters 
advocating antibiotic stewardship.  
Engagement of all clinic staff as an 
intervention had a positive impact but 
this was not routinely done. 
Level I 
Good 
Meeker, D., Knight, T. 
K., Friedberg, M. W., 
Londer, J. A., 
Goldstein, N. J., Fox, 
C. R., . . . Doctor, J. N. 
(2015). Nudging 
Guideline-Concordant 
Antibiotic Prescribing: 
A Randomized Clinical 
Trial. JAMA Internal 
Medicine, 1-15. 
 
Evaluated a 
behavioral 
technique which 
was a “nudge” 
based on provider 
commitment for 
the judicious use 
of antibiotic 
therapy for upper 
respiratory 
conditions. 
Antibiotic prescribing 
rates for acute 
respiratory infections that 
were inappropriate at 
baseline and 
intervention.   
 
Randomized 
Control Trial.  
Poster sized 
commitment 
letters in 
exam rooms 
with provider 
photo and 
signature 
stating 
commitment 
to avoiding 
inappropriate 
Baseline rate for no poster 43.5% and 
for poster 42.8% at intervention. No 
poster increased to 52.7% while poster 
decreased to 33.7%.  Poster resulted in 
a 19.7 absolute percentage decrease in 
inappropriate antibiotic prescribing for 
acute respiratory infections.  This 
intervention was low-cost and simple to 
implement with positive results. 
Level II 
Good 
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Citation (APA) Purpose Intervention Design Outcome LOE 
Quality 
antibiotic 
prescribing. 
Rosenfeld, R. M., 
Piccirillo, J. F., 
Chandrassekhar, S. 
S., Brook, I., Kumar, 
K. A., Kramper, M., . . 
. Corrigan, M. D. 
(2015). Clinical 
Practice Guideline 
(Update): Adult 
Sinusitis. 
Otolaryngology-Head 
and Neck Surgery, 
I52(2S), S1-S39. 
doi:10.1177/01945998
15572097 
 
Clinical Practice 
Guideline 
(Update) Adult 
Sinusitis 
Evidence-based 
recommendation to 
manage adult 
rhinosinusitis.  
Systematic review of 42 
articles.  Expert opinion.  
Information for patient 
education, creation of a 
new algorithm, delayed 
prescribing indications. 
Update of the 
2007 
guideline. 
Improve diagnostic accuracy for adult 
rhinosinusitis, promote appropriate use 
of PCT for diagnosis confirmation and 
management and promote judicious 
use of systematic and topical therapies.  
Opportunities for quality improvement 
and the creation of explicit 
recommendations for implementation 
into clinical practice. 
Level I 
Good 
Schmidt, M. L., 
Spencer, M. D., & 
Davidson, L. E. 
(2018). Patient, 
Provider, and Practice 
Characteristics 
Associated with 
inappropriate 
Antimicrobial 
Prescribing in 
Ambulatory Practices. 
Infection Control and 
Hospital 
Epidemiology, 39(3), 
307-316. 
Explained factors 
associated with 
inappropriate 
antibiotic 
prescribing. 
Evaluation 
included 448,990 
outpatient visits 
for common 
respiratory 
conditions that 
should not require 
antibiotic therapy.   
Data extraction to include 
diagnosis for which 
antibiotic prescribing was 
not appropriate. 
 
Retrospective 
cohort study. 
Outcome of 
interest was 
antibiotic 
prescribing at 
the visit.   
Individual provider characteristics as 
well as individual patient characteristics 
were associated with increased rates of 
inappropriate antibiotic therapies.  
Antibiotic stewardship programs in the 
outpatient setting must have a 
multifaceted approach to interventions 
for successful outcomes and best 
patient care. 
Level IV 
Good 
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Citation (APA) Purpose Intervention Design Outcome LOE 
Quality 
doi:10.1017/ice.2107.
263 
 
Zoorob, R., Sisani, M. 
A., Fremont, R. D., & 
Kihlberg, C. (2012). 
Antibiotic Use in Acute 
Respiratory Tract 
Infections. American 
Family Physician, 
86(9), 817-822. 
 
Clinical 
Guidelines for 
appropriate 
antibiotic use for 
common upper 
respiratory 
conditions 
Evidence-based 
recommendation for the 
management and 
treatment of common 
cold, influenza, 
rhinosinusitis, otitis 
media, pharyngitis & 
tonsillitis, laryngitis, 
epiglottitis, and bronchitis 
& tracheitis.  Systematic 
review of current 
research. 
Guideline Indications for appropriate antibiotic 
therapies for common upper respiratory 
infections frequently seen in family 
practice.  The use of antibiotics based 
on best evidence-based guidelines will 
help prevent adverse events and drug 
resistance.   
Level I 
Good 
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Appendix F 
ANTIBIOTIC STEWARDSHIP PROGRAM 
 
Thank you for completing the following survey, your help is greatly appreciated. 
 
1.  True or False:  Antibiotic overuse has contributed to the problem of increased drug 
resistance. (TRUE) 
2.  True or False:  For acute cough or bronchitis lasting for 1 week, antibiotics are indicated. 
(FALSE) 
3.  True or False:  All patients with a fever require antibiotics. (FALSE) 
4.  True or False:  To decrease antibiotic use delayed antibiotic prescribing is an appropriate 
technique for providers to utilize. (TRUE) 
5.  True or False:  Bronchitis or acute cough can last up to three weeks. (TRUE) 
6.  On a scale of 1 to 5, how often do your patients request antibiotics unnecessarily?   
1. very often 
2. often 
3. neutral 
4. not often 
5. never 
7.  On a scale of 1 to 5, how likely are you to incorporate antibiotic education into your clinic 
visits with patients?  
1. extremely likely 
2. likely 
3. neutral 
4. unlikely 
5. extremely unlikely 
8.  On a scale of 1 to 5, how helpful would you say an antibiotic stewardship program promoting 
best practice is?    
1. extremely helpful 
2. helpful 
3. neutral 
4. not helpful 
5. extremely not helpful 
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9.  On a scale of 1 to 5 how likely are you to incorporate delayed prescribing (WASP) into your 
practice?   
1. extremely likely 
2. likely 
3. neutral 
4. unlikely 
5. extremely unlikely 
10.  On a scale of 1 to 5 how important would you say antibiotic education is for the public?  
1. extremely important 
2. important 
3. neutral 
4. somewhat important 
5. extremely not important 
Would you be willing to provide the following information? Please mark the appropriate answer. 
MD______ NP______ 
Age______ Gender______ 
Years of Practice__________ 
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